University of New Mexico

UNM Digital Repository
Chemical and Biological Engineering ETDs

Engineering ETDs

2-1-2012

Fabrication and characterization of synthetic
substrates for use in rigidity cell culture studies of
valvular interstitial cells for aortic valve tissue
engineering
Alexander T. Leonard

Follow this and additional works at: https://digitalrepository.unm.edu/cbe_etds
Recommended Citation
Leonard, Alexander T.. "Fabrication and characterization of synthetic substrates for use in rigidity cell culture studies of valvular
interstitial cells for aortic valve tissue engineering." (2012). https://digitalrepository.unm.edu/cbe_etds/53

This Thesis is brought to you for free and open access by the Engineering ETDs at UNM Digital Repository. It has been accepted for inclusion in
Chemical and Biological Engineering ETDs by an authorized administrator of UNM Digital Repository. For more information, please contact
disc@unm.edu.

Alexander T. Leonard
Candidate

Chemical and Nuclear Engineering
Department

This thesis is approved, and it is acceptable in quality and form for publication:
Approved by the Thesis Committee:

Dr. Elizabeth L. Dirk

, Chairperson

Dr. Steven Graves

Dr. Heather Canavan

i

FABRICATION AND CHARACTERIZATION OF SYNTHETIC
SUBSTRATES FOR USE IN RIGIDITY CELL
CULTURE STUDIES OF VALVULAR INTERSTITIAL CELLS
FOR AORTIC VALVE TISSUE ENGINEERING
By

ALEXANDER T. LEONARD
B.S. CHEMICAL ENGINEERING, COLORADO STATE UNIV

THESIS
Submitted in Partial Fulfillment of the
Requirements for the Degree of

Master of Science
Chemical Engineering
The University of New Mexico
Albuquerque, New Mexico

December, 2011

ii

ACKNOWLEDGMENTS
I acknowledge Dr. Elizabeth Hedberg-Dirk, my advisor and committee chair, for
her continuing support to push the limits of my knowledge, requiring my best at all times.
Her encouragement to attend graduate school in the first place has helped me to grow
professionally and personally. I will carry these experiences with me for life.
I thank Dr. Heather Canavan for her professional guidance and uncompensated
time, instructing me in and out of the classroom. Her willingness to extend a helping
hand is a quality I hope to reflect in the future. To Dr. Steven Graves, thank you for your
valuable time, serving on my committees. Your advice and guidance has proven to be
invaluable.
My editors and group members; Dr. Linnea Ista, Dr. Thomas Corbitt, Dr. Dimitri
Dascier, Dr. Eunkyung Ji, Scott Spangler, Kirsten Cicotte, Mathew Rush, and Kristen
Wilde this document is a direct reflection of your time and thoughtful inputs.
Additional thanks to Michael Brumbach (Sandia National Laboratories, SNL) for
obtaining XPS spectra, Dr. Kateryna Artyushkova and Dr. Jamie Reed (University of
New Mexico, UNM) for assistance in the analysis of XPS spectra and Dr. C. Jeffrey
Brinker (UNM, SNL) for access to the AFM which was performed by Matthew Rush.
The data for the compressive modulus and glass transition was obtained by Kirsten
Cicotte at SNL. Spectral images for the quantification of ICC staining were obtained by
Genevieve Phillips at the UNM Cancer Research Facility. Your experience and
knowledge has enabled the incorporation of a variety of techniques otherwise
unavailable. These few words cannot portray my thankfulness. Special thanks to Dr.
Kristi Anseth (University of Colorado, Boulder) for insightful discussions.

iii

I extend a great appreciation to my family who has supplied unlimited support
and love throughout my graduate career.
A heartfelt thank you to my friends, who have always offered temporary escapes
from reality to maintain my sanity. Finally, my mountain bike race sponsors, Bikeworks
ABQ and Tomac Mountain Bikes, who thought highly enough of my abilities and
personality to support me, although my fitness varied based on my workload.

iv

Fabrication and Characterization of Synthetic Substrates for Use in Rigidity Cell
Culture Studies of Valvular Interstitial Cells for Aortic Valve Tissue Engineering
By
Alexander T. Leonard
B.S. Chemical Engineering, Colorado State University, 2008
M.S. Chemical Engineering, University of New Mexico, 2011

ABSTRACT
More than 100,000 Americans each year undergo aortic valve (AV) replacement
due to valve failure. An AV can become diseased, impairing the proper function of the
valve. Common treatments for a defective valve are either replacement with a
decellularized biologic or a synthetic valve. These treatments options are limited by short
functional lifetime and thrombogenic surfaces. Tissue engineered heart valve will have
the ability to integrate with the surrounding tissue as well as to repair and remodel.
However, a greater understanding of valve cell biology is required to induce analogous
tissue formation. A diseased valve is associated with stiffening of the tissue. Researchers
have probed the impact of stiffness on cell function, but have had results complicated by
in vitro models used.
The synthetic materials commonly used to fabricate cell culture platforms with
varied moduli are limited in applicability due to a restricted range of achievable moduli
and/or surface instabilities. The copolymer network n-octyl methacrylate (nOM) and
diethylene glycol dimethacrylate (DEGDMA) offers attractive material properties that
overcome these limitations. We have fabricated co-polymer networks with 3 to 33 wt%
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DEGDMA with bulk compressive modulus of 25±2 to 4700±300 kPa. Nanoindentation
determined cellular level mechanics of the nOM / DEGDMA ranged from 6.5 ± 0.00 to
1,562.5 ± 192 MPa. The networks demonstrated consistent surface properties of
wettability/hydrophobicity, chemical composition and topography. The nOM/DEGDMA
substrates vary in modulus over three orders of magnitude while maintaining comparable
chemical and topographical surface features.
The primary cells of the AV, valvular interstitial cells (VICs), were cultured on
the nOM/DEGDMA substrates. It was found that the rate of proliferation was not
impacted by the stiffness of the culture platform. Expression levels of phenotypic
markers for the active and osteoblastic-like were not affected by the stiffness of the
substrates. Production of collagen-I and sulfated glycosaminoglycans did not change
between the different substrate moduli. However, elastin production was significantly
upregulated on the softest materials. We have fabricated a cell culture platform that is
capable of varying over a three orders of magnitude of a physiologically relevant range,
and used it to study the changes of VIC functions.
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Chapter 1 : Aortic Heart Valve and 2D Substrates

1

1. Introduction
Approximately 100,000 Americans each year must undergo aortic valve (AV)
replacement due to disease or dysfunction.3, 5, 6 An improperly functioning AV increases
the strain on the heart from improper opening or closing of the valve.6-9 Common
treatment of a defective valve is replacement with either a biologically isolated or a
synthetic valve.7, 10 Bio-prosthetic valves have the drawback of a limited functional
lifetime of ~10-15 years. This limited lifetime is attributed to the decellularization
process, removing the cells that continually remodel structural components of the AV.
The decellularization process also damages the extracellular matrix (ECM), further
limiting the valves‘ ability to last in the body. Synthetic valves are structurally reliant,
but have thrombogenic surfaces that can cause blood clots, requiring the patient to remain
on lifetime anticoagulation therapy.7 The generation of living AV constructs that are
capable of integration with surrounding tissue, growth and maintenance of homeostasis
will overcome the limitations of these current therapies. However, an incomplete
understanding exists of how to induce the cells that occupy the AV to produce ECM.
Development of materials that are capable of directing the cellular functions of the
native cells of the AV to promote normal cell functions is necessary to develop a living
prosthesis. Heart valve cells (and other mammalian cells) respond to multiple influences
including soluble factors and substrate interactions.11, 12 The interactions cells have with
a substrate are dependent on the mechanics, topography and/or chemistry of an
underlying substrate.13-15 Although mammalian cells are on the order of magnitude of
tens of microns, changes in substrates on the nanometer scale can have a profound impact
on many cellular functions.16, 17 With this knowledge, cellular environments can be
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engineered to direct cell functions. However, the problem is complicated by the fact that
each type of cell will respond differently to the same stimulations. This makes it critically
important to independently engineer each material for each cell type.
Substrate modulation of cell response begins with cellular adhesion. The
attachment of cells through adsorbed proteins on a material‘s surface begins a cascade of
intercellular and extracellular signaling.14, 18 Once a cell is attached to a surface, tension
generated by the cells cytoskeleton mediates the many intercellular signaling cascades
through trans-membrane force sensing proteins. This type of cellular response to its
environment is defined as mechanosensing. Changes of the mechanical environment of
the cell can lead to alterations in the genetic and protein expression patterns of the cell
through mechanosensing.14, 18-20 For example, exposure to various substrate moduli has
been shown to cause fibroblasts and osteoblasts to adapt by reorganizing the internal
cytoskeleton.19 Mechanosensing is critical in the human body as it allows cells to operate
in a wide range of tissues, all with different mechanical properties directly related to the
function. The soft tissues in the body can range from very soft (such as the liver with a
elastic modulus of ~1 kPa21) to the arterial wall (~1 MPa22) and finally cortical bone ( ~5
GPa23).

2. Aortic Heart Valve
2.1. Anatomy and Function
The heart has four unidirectional valves that control both the flow of blood within
the heart as well as in the entire cardiovascular system. The heart valves are divided into
two categories: the artioventricular and semilunar.1 The artioventricular valves are
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responsible for controlling flow into the ventricles from the left (mitral valve) and right
(tricuspid valve) atria. Simultaneously, the three cusped, semilunar valves control the
flow leaving the heart from the left (aortic) and the right (pulmonary) ventricles into the
aorta and pulmonary arteries, respectively.24, 25 Figure 1-1 shows the anatomy of the heart
with the left and right atria removed to display the valves.
The left and right sides of the heart serve different purposes; the patient‘s right
atrium receives venous blood passes it to the right ventricle pressurizing it to
approximately 20 mmHg to deliver blood to the lungs through the pulmonary artery. The
left atrium receives oxygenated blood from the lungs and further pressurizes the flow to
approximately 120 mmHg in the aorta.3 The AV must withstand the most demanding
hydrodynamic environment of the heart with the highest pressures and blood flows to
deliver blood to the rest of the body.

Figure 1-1. Top view of the heart with the left and right artiums removed to view the atrioventricular valves,
tricuspid (T.V.) and mitral (M.V.) valve. The semilunar valves pulmonary (P.V.) and aortic (A.V.) are seen near the
center of the image. The right coronary artery (R.C.A.) descends off the aorta after the aortic valve. Heart is seen
1
with patient’s right on the left side of the image.
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The aortic valve is composed of three leaflets, which separate during opening
(systole) and come back together to create a seal when closed (diastole). The three cusps
meet in the center of the aorta at a thickened area of the valve called the node of
Arantii.26 The AV cycles approximately 70 times per minute with fluid velocities as high
as 5 liters per minute.3 The AV is opened when the left ventricle contracts, increasing
pressure within the ventricle. When blood has exited the left ventricle, pressure
differential between the aorta and the empty ventricle causes the AV to close. An AV is
subjected to three distinct types of forces during a single cardiac cycle: tension (closure),
flexural (opening), and shear (blood ejection).7, 8 As seen in Figure 1-2, each cusp is
approximately 1 mm thick, and is comprised of three distinct layers: the fibrosa,
ventricularis and the spongiosa.2, 27, 28 These layers provide the valves ability to resist all
of the forces applied on it and move anisotropically. The valve leaflets in healthy normal
function are avascular and rely on the diffusion of nutrients and oxygen to support normal
function. The AV is able to withstand these different forces and anisotropic movements
by the macro and micro structure of the ECM, which is maintained by the cells of the
valve.2, 28, 29 Thus, an engineered heart valve must mimic these properties for optimal
function.

Figure 1-2. Histological cross section of an aortic valve cusp, with the three distict layers. The fibrosa on the aortic
side of the valve, spongiosa fills the interstitial space and the ventricularis on the ventricle side.
(http://cohesion.rice.edu)
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2.2. Disease and Current Treatments
Disease of the AV results in approximately 15,000 patient deaths per year in the
United States. In addition to complete valve failure, 30% of adults over 65 years old
suffer from early stages of valve malfunction.30 This results in 100,000 heart valve
surgeries per year, at an approximate total cost of $14 billion.5, 31 Function of the AV can
become impaired by congenital defects, age related failure and infection. Failure of the
AV is classified in two different categories, stenosis (valve is unable to fully open) and
regurgitation (valve is unable to fully close). Both types of disease increase the load on
the left ventricle, as well as strain on the rest of the cardiovascular system. A
malfunctioning AV increases the likelihood of death related to a cardiovascular disease
(heart attack, stroke, etc.) by 50%.32 Cures of AV disease by pharmaceuticals is still in
early stages and treatments had limited success, leaving surgical replacement as the only
treatment option, either with a synthetic or a decellularized biologic valve.3
Synthetic valves are currently fabricated using pyrolytic carbon coated metal. These
mechanical valves are structurally dependent, but are limited by their complex geometries
that induce thrombosis. 33 The thrombogenic surfaces of these valves require a patient
stay on anticoagulant therapy for the remainder of their life.34 An attractive alternative is
the use of biologically isolated valves: autografts (Ross procedure), homografts
(transplant) or xenografts (porcine, bovine).9 Examples of both a synthetic and biologic
valve are shown in Figure 1-3, with the fabric suture ring shown on both samples. While
the biologic valve offers non-thrombogenic surfaces, the durability of the valve is limited.
In adults older than 65 that are relatively inactive, a decellularized biologic valve can last
20 years. In younger, more active patients, the functional lifetime of the valve can be
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decreased to less than five years.35 The failure of a decellularized biologic valve results in
either patient death or reoperation. The limitations of current treatments with biologic and
synthetic valve replacements have spurred research to develop a tissue engineering
solution that could produce a living valve capable of recapitulating the healthy structure
and function of the AV. These valves will be populated by native cells, integrating with
surrounding tissues of the patient.

Figure 1-3. Examples of a mechanical (A) and biologic (B) heart valve replacement. (http://www.medtronic.com)

2.3. Microstructure of the Extra Cellular Matrix
The structure and the arrangement of the ECM components in the valve are critical to
withstand the forces that are placed on it during healthy function. Microstructure
components responsible for function and durability range from sheets of aligned fibers to
hydrogel networks. Each of the three layers of the valve contains different amounts of
collagen, elastin and glycosaminoglycans (GAG) that provide the needed functionality.
The ventricularis dominates the elastic response during the end of the diastole phase.29
The elastin fibers of the ventricularis give the valve its flexibility to return to the closed
position at the end of the diastole phase. These fibers are radially aligned and stretch
during opening and contract during closing. (Figure 1-4A).2 Elastin is highly extensible
(εmax 150%) changing chain conformations based on tensile forces. This high
7

extensibility is attributed to a highly- crosslinked network of alternating hydrophobic and
hydrophilic domains. A measure of single elastin fibers by Aaron and Gosline found an
approximate Young‘s modulus of 1 MPa.36
In contrast, the fibrosa withstands the tension that is placed on the valve by the high
pressure in the aorta by behaving inelastically through circumferentially aligned collagen
fibers packed into bundles. These collagen bundles resist tension along the axis of the
fiber. (Figure1-4 B and C).37 However, to allow the valve to move as required the
collagen fibers exist in two conformations. During systole, the collagen fibers are
corrugated and offer little resistance to opening the valve. When the valve is placed under
tension, the collagen fibers uncrimp and prevent the valve from collapsing into the
ventricle.4 The very low extensibility of type I collagen (εmax 10 -50%, depending of
extent of crosslinking) gives the fibrosa ability to resist the strain associated with diastole.
Type I collagen self-assembles into arrays of fibrils which are then enzymaticaly
crosslinked to form ‗solid‘ fibers. These fibers can then be assembled into bundles The
extent of crosslinking can vary the Young‘s modulus of the collagen fiber from 200 to
7500 MPa, allowing the tissue to be locally tuned to resist strains.38

Figure 1-4. Electron micrographs of isolated structural fibers in the aortic valve. The structure and composition of
the valve varries to allow for the highly anisotropic movements. Alligned elastin fibers from the ventricularis (A)
allows the valve to stretch during systole while the crimped collagen fibers (B) allow the valve to open but then
1, 2
during diastole uncrimp and resists the tensions during diastole (C).
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The spongiosa serves as the lubrication between the fibrosa and ventricularis. Highly
hydrated glycosaminoglycans (GAGs) (chondroitin sulfate, dermatan sulfate, hyaluronan)
in the spongiosa allow for the anisotropic movement of the valve cusps.39 Isolated free
standing hydrogels composed of GAG have been found to have a bulk modulus an order
of magnitude lower (10 kPa) than the fibril components of the valve. The relationship
between these different layers during cyclic movement of the valve is represented in
Figure 1-5. To function properly, the valve is highly dependent on the orientation and
arrangement of the structural components of the valve. The mechanics of the individual
collagen, elastin and GAGs allow for the proper anisotropic movements of the valve. The
array of structures and mechanics of a native healthy valve provide a highly diverse
structural environment for the cells that occupy the valve.

Figure 1-5. Pictorials diagram of a single leaflet in opening and closing in relation to the movements of
4
the internal fibers of the valve.
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2.4. Aortic Valve Cells
The micro and macrostructure of the AV is extremely important to maintain
function in the demanding environment at the base of the aorta. The highly cyclic
movement of the valve puts large stresses and strains on the structural components of the
valve and without continuous remolding of these structural proteins it would be
impossible to maintain function over an entire lifetime. The remolding and the regulation
is performed by two primary cell types that occupy the AV. The cells are the valvular
interstitial cells (VICs) and valvular endothelial cells (VECs).40
The ideal cells to use in research for tissue engineering of the AV would be
healthy and disease-free human cells. However, due to the inaccessibility of the AV, as
well as the high degree of valve co-morbidity in chronic cases, healthy human cells are
extremely rare. Sources for disease free human cells are, thus limited to acute traumatic
non-cardiac injuries and rejected donor tissue. The amount of usable tissue is further
limited as many rejected donor tissues contain inflammation or pathology from either the
recipient or the donor.41, 42 Other cell types have been evaluated as potential model cell
sources, such as bone marrow mesenchymal stem cells (MSCs) and smooth muscle cells
(SMCs) of the ascending aorta. The SMC displayed similar rates of proliferation, but
VICs produced ECM components at a much higher rate in collagen hydrogels.43 While
MSCs showed similar response of collagen production to mechanical forces, the MSCs
were more sensitive to any osteogenic compounds.44 All of these factors require that
animal models must be used to acquire healthy cells. Cells of the AV have been isolated
from porcine, bovine, ovine, canine, and rodents (mouse, rat, hamster and chinchilla).3
Cells isolated from the porcine model have become the primary in vitro model. The
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porcine model is selected as it has similar cell size, valve hemodynamics, and
homologous genome to a human.45 For these reasons the remaining work discussed is
regarding the cells of the porcine model.
The outer most layer of the AV is composed of a single layer of VECs. The VECs
and other cardiac endothelial cells share the similar responsibility: to maintain the nonthrombogenic outer surface of the valve. The AV endothelium is distinct from that of the
aorta and the ventricle, which is attributed to a distinctive linage during embryonic
development.3 While other cardiac cells are aligned parallel to the flow of blood, VECs
align themselves circumferentially across the surfaces of the valve.46 The VECs not only
provide a non-thrombogenic surface, but also transmit nutrients and biochemical signals
into the AV. 47 It has been shown that VECs are highly responsive to shear stress from
surrounding fluid. The average shear stress associated with the ventricular surface is
approximately 20 dynes/cm2, with the arterial side having an order of magnitude lower
stress.24 The difference in shear stress is believed to be the cause of site specific VEC
expression of many factors including caspase-3, tumor necrosis factor-α and bone
morphogenetic factor-4.31 The VECs are believed to regulate the homeostasis of the AV
by signaling to the VICs through these cytokines.
The VICs are present in all layers of the valve and are responsible for the
remodeling of structural valve components. To contend with the need to continually
repair the micro failures of the structural components of the valve, VICs have a higher
level of protein and GAG turnover coupled with a higher rate of proliferation as
compared to many other cell types.48 Any cell in the AV that is not a VEC is classified as
a VIC, and as a result, the VIC population is highly heterogeneous.49 This diverse
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population is broken into five different phenotypes: embryonic (eVIC), progenitor
(pVIC), quiescent (qVIC), activated (aVIC), and osteoblastic (obVIC).49 The eVICs are
only present in the developmental stage of the aortic valve; all other types can co-exist in
a single valve.50 In healthy valves, the predominant VIC phenotype is considered the
qVIC which is characterized as fibroblast-like with elongated spindle-shaped
morphology.49 The qVIC population in the valve is thought to regulate low levels of
ECM turnover and inhibit angiogenesis into the leaflet.51 During injury or disease, qVIC
are activated to become aVICs; characterized as smooth muscle cell-like with roundrhomboid to elongated morphologies.49 The aVICs are associated with higher rate of
ECM turnover, proliferation and migration marked by alpha-smooth muscle actin
(αSMA) expression.52 After repair of damaged/diseased tissues, aVICs are deactivated or
undergo apoptosis. If the deactivation of aVICs to qVICs is disrupted, disease (fibrosis,
angiogenesis, inflammation and calcification) of the valve tissue can result. In vivo,
obVICs are observed in later stages of disease and are associated with regions that
contain cartilaginous nodules and mature lamellar bone. 53, 54
To study the transition between the aVIC and obVIC states, in vitro studies
require the addition of specific cytokines (BMP-2 and -4, TGF-β1) and organic calcium
(ascorbic acid, β-glycerol phosphate). 55 Representative images of these phenotypes in
two-dimensional culture are shown in Figure 1-6. The final phenotype pVIC, can account
for as much as 10% of the VIC population and has markers associated with bone marrow
derived mesenchymal stem cells.3 It has been hypothesized that these cells are associated
with valve disease and the differentiation into obVICs. A subset of these pVICs are
positive for both αSMA and collagen. The relationship between the cells and the
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underlying substrate has also been shown to facilitate the transition of the VICs from one
phenotype to another.49

Figure 1-6. Images of the different phenotypes of VICs in vitro culture, qVIC , aVIC, obVIC.

3

The influence of soluble factors on VIC phenotype has been extensively
studied.44, 49, 50, 54, 56 It has also been demonstrated that the substrate on which the cells are
cultured also plays a large role in regulation the phenotypes. Yip et. al examined the
relationship between the substrate material stiffness and VIC phenotypic expression. Two
different substrates were fabricated using collagen fibers (~0.12 µm) with matrices of
varying thicknesses to produce a compliant (2 kPa bulk modulus) and stiff (6.0 kPa bulk
modulus) substrates. VICs cultured in media with components (β-glycerophosphate,
ascorbic acid, dexamathesone) known to induce differentiation to obVIC lineage on the
substrates showed that the compliant matrices promote osteoblastic differentiation and
aggregation; however, cells cultured on stiffer matrices showed an increase in apoptosis,
calcium deposition and proliferation. The stiffer matrices also made the cells more
sensitive to the addition of TGF-β1, increasing the number of cellular aggregates. These
results indicate that VIC function is related to the stiffness of the culture matrix as well as
soluble factors.55 Benton et al. compared tissue culture polystyrene (TCPS) and
13

poly(ethylene glycol) hydrogels coated with either fibrin or fibronectin and found that the
unmodified and modified TCPS increased expression of markers associated with
calcification and osteoblastic differentiation (alkaline phosphatase, αSMA, core binding
factor-1 (CBFa-1)). The more compliant PEG hydrogels showed decreased levels of all
for osteoblastic markers.57 These two studies exemplify the importance of defining cell
culture substrate properties.
The response of VICs to a substrate is not limited to the rigidity but is also
affected by the hydrophobicity and roughness. Pedron et al. fabricated a gradient
hydrogel capable of variations in modulus, roughness and hydrophobicity on a single
surface to determine if preferential attachment of VICs occurred.58 After a 48 hour
culture period, it was observed that VICs tended to gravitate to the stiffer (Er ~100 MPa),
rougher (Rrms ~20 nm) and hydrophilic (Contact angle ~20°) regions of the gel.58 These
studies have indicated that the relationship between the culture substrate and cellular
function of VICs requires a greater understanding and must be explored more. However,
the substrates currently used do not isolate individual variables and it is difficult to
deconvolute the actual substrate variations inducing the changes in VIC behavior.

3. 2D Cell Culture Platforms
3.1. 2D Materials to Study Impact of Rigidity and Topography
It has been demonstrated through numerous experiments using a wide variety of cell
types that the material properties of an underlying substrates play a vital role in
modulating cellular response both in vivo and in vitro59-63. Cellular functions such as
adhesion and spreading, proliferation, and gene expression are affected by many
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chemical and physical factors of a substrate, including but not limited to exposed
chemical groups, surface topography, and mechanical properties.13 Studies that have
focused on the effects of mechanical properties have been limited due to a lack of
materials that are capable of isolating the effects of stiffness over a wide range without
changes in surface chemistry and/or topography.64 To mimic the environments presented
to VICs in vivo, a specific material platform is required to engineer topography and
rigidity independently. The wide range of mechanics that exists in the AV structural
components (kPa to GPa) as well as the variation of topographical features requires a
material platform that can be easily fabricated to have the specific properties to mimic the
native valve.

3.2. Materials Based on Natural Polymers for Rigidity
Materials commonly used for examining the effects of substrate rigidity can either be
classified as natural or synthetic. Natural materials are generally crosslinked extracellular
matrix polymers. These materials can be tailored with various moduli by varying protein
concentration, stiffening cofactors, crosslinking density and substrate mounting.65 Some
natural substrates used for rigidity manipulation consist of fibrin, collagen and
polysaccharides.60 Substrates composed of natural polymers have been shown to exhibit
elastic moduli of 0.001 kPa to a maximum of 150 kPa. Collagen and fibronectin
substrates cover the lowest range with elastic moduli of 0.001 to 1 kPa and alginate gels
ranging from 0.1 to 150 kPa.65 Natural polymers offer the benefits of biocompatibility
and cell adhesion. The reason that natural polymers make such a good cell substrate also
makes them poor substrates for rigidity manipulation studies. The complex and bioactive
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extracellular matrix proteins can directly interact with the cell. These interactions make it
difficult to discern if the resulting cell response is due to the variation of cell/material
adhesion or substrate rigidity.13 These reasons make natural polymer based substrates
difficult to use as a model platforms to understand the role of rigidity in cell functions.

3.3. Materials based on Synthetic Polymers for Rigidity
Synthetic substrates are able to overcome the limitations of low modulus and complex
cell adhesion associated with natural polymer based substrates. Synthetic substrates can
be fabricated with precise surface features for localized adhesion.60 Synthetic substrates
can be made from a variety of materials such as ceramics, metals and polymers.66 We are
focused on polymeric substrates due to the relative ease by which the materials can be
chemically and mechanically altered. The modulus of these networks can be varied by
co-polymerization of different monomers and/or addition of a crosslinking agent and
polymer blending.13, 60, 64, 65
Some synthetic polymer networks used for rigidity manipulation include
polyacrylamide (PA), polydimethylsiloxane (PDMS) and more recently poly(ethylene
glycol) (PEG).64 The substrates based on PA and PDMS have been some of the more
widely studied. The moduli can be easily modified by the crosslinker to polymer ratio.
Acrylamide monomers are crosslinked with bis-acrylamide using radical polymerization,
and have been characterized with elastic moduli of 0.1 to 100 kPa.65 As soft tissues in the
body range 1kPa to 1 MPa, this limits PA gels to the study of the lower range of soft
tissue.64, 65 PDMS is able to overcome this limitation with elastic moduli in the range of
10 kPa to 1 MPa. A simple variation in base to curing agent ratio produces this wide
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range of material modulus.67 PDMS covers a much broader range of the soft tissue
moduli range than PA. However, PDMS is unable to support a long-term cell adhesion
layer, due to its hydrophobicity and high chain mobility at the surface.64, 67 Poly(ethylene
glycol) (PEG) hydrogels allow for independent control of biochemical and mechanical
properties, but require additional functionalization of the material to allow for cellular
adhesion.64, 68, 69 A summary of the synthetic materials used for cell rigidity studies is
shown in Figure 1-7. To further the understanding of the relationship between a
substrate‘s rigidity and cellular functions, it is necessary to develop a substrate with an
easily tunable modulus that maintains stable surface chemistry and topography over a
broad range of moduli.
1 kPa

1 MPa

1 GPa

Rigidity Found in Valve

Crosslinked Hydrogels
Polyacrylaminde Gels
Polydimethylsiloxane

Figure 1-7. Summary of materials commonly used in cell rigidity studies along with the general range of achievable
64, 65
elastic modulus for each material.

3.4. Ordered Nanoscale Surface Topography Cell Culture Substrates
The conformation and orientation of the proteins adsorbed on a surface influence how
a cell interacts with the surface. The addition of nanotopography to a surface affects
either specific or nonspecific adsorbed proteins. The topography changes the
conformation, orientation, and spacing of the proteins and thus the resulting cell
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interactions. 70 Methods to fabricate submicron topography produce either ordered or
unordered topography, each applicable for different interactions. Unordered topography
methods exploit topographies that spontaneously occur under controlled processing
conditions. Examples of techniques that produce unordered topography include polymer
demixing, colloidal self-assembly and chemical etching.16, 71, 72 Ordered topographies
produce prescribed patterns and geometries capable of closely mimicking natural
structures. The precise features are generated with electron beam lithography,
photolithography or focused ion beam lithography.16, 71
The current work focuses on the ordered methods that produce substrates with
structural features that mimic the native heart valve ECM. Producing these ordered
features is generally time consuming, requires expensive equipment and precise
knowledge of the submicron structure of tissues.16, 70 Directly writing ordered patterns on
materials for cell culture is impractical because the time and materials required to
fabricate an individual substrate.71 This limitation can be overcome by coupling the
ordered techniques in series with nanoimprint lithography (NIL). NIL allows for the
production of a single master mold that is used to pattern multiple subsequent materials
by mechanical contact.73 Several variations exist of NIL, however, the basic use of the
same using a master mold to shape a liquid then varying methodologies to cure the liquid
while the liquid is still in contact with the mold. When the mold is removed the negative
of the mold structures remains on the imprinted surface. 73-75 A schematic is shown in
Figure 1-8, where the master is brought into contact with the material to be patterned.
The printed material is cured generally through changes in temperature of exposure to
ultra violet light.
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Figure 1-8. Schematic of NIL, bringing a mold fabricated with a 3D structure that is into mechanical contact with a
liquid material that is cured into the negative shape of the master.[72]

Examples of materials that have been successfully printed using NIL include
silicon, poly(methylmethacrylate) (PMMA) and poly(dimethylsiloxane) (PDMS). 71
Feature sizes down to 100 nm have been reported imprinting with PDMS. The feature
size is limited by the elasticity of the bulk material. As a PDMS mold is pressed into the
material to be imprinted the mold deforms and resolution of the original mold is
decreased.76 Use of rigid mold increases the resolution possible, as the mold does not
deform with the pressure of mechanical contact. Silicon wafers and PMMA can be used
to produce feature sizes down below 25 nm.77 The trade off is that rigid molds become
more difficult to release from the cured material, and damage to both the mold and
imprinted material can occur when separating the materials.74 The development of
techniques for sub-micron patterning has now given bioengineers new tools to expand the
type of cell culture substrates that can be produced to mimic native structures.
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4. Summary
The VICs of the AV exist in a highly diverse mechanical and topographical
environment. It is necessary to engineer substrates with control of both topography and
bulk modulus. The natural tissue of the AV has a hierarchical structure critical for proper
function of the valve: the macro structure (1 mm thickness), the micro-structure (1 µm –
1 mm) and nano-structure (< 1 µm). The culture environment plays a large role in the
regulation of the VIC phenotype. The studies that have been preformed to study these
impacts have been limited. Previous test substrata were plagued with problems of
variation of surface properties as a result of the changes in the modulus, and thus affected
the protein adsorption properties on the surface and finally the cell-material interface.
With the exception of PDMS, there is little crossover between substrates used to engineer
submicron surface topography and bulk material modulus. To truly understand the
relationship that the VICs have with the physical environment, it is necessary to design a
cell substrate capable of mimicking both topographical features and the mechanical
environment present in a healthy valve. New cell culture platforms are needed to discover
the appropriate conditions to induce specified cell functions. These new cell platforms
will allow for the expansion of knowledge to develop a living tissue alternative to the
current replacement therapies for valve disease.
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1. Introduction
The fabrication and characterization of a new cell culture substrate is examined.
The goal was to fabricate a cell culture platform that varies material modulus over several
orders of magnitude, while maintaining similar surface features across the mechanical
range and is easily fabricated. Here we examine the use of mono and di-methacrylate
system as a cell culture platform. The platform is capable of variations in bulk modulus
while maintaining the surface features.
Changes in surface topography, surface energies, and chemical functional groups
usually accompany changes in a material‘s stiffness.1-3 The alterations in surface
properties will all affect the way that biomolecules adsorb onto a surface and that can
affect how the cells adhere to those biomolecules.4 It is therefore required to have precise
control of substrate‘s surface properties to control cellular interactions and manage
cellular response. The variation of surface properties is a major limitation of previous
substrates used to study the impact of substrate modulus on cellular function.
Current materials in use to evaluate the cellular function impact from the
material‘s mechanical properties include cross-linked hydrogels, polyacrylamide (PA),
and polydimethylsiloxane (PDMS).5, 6 For example, hydrogels with an elastic modulus
ranging from 0.001 to 150 kPa lack the rigidity to model stiff tissues. 2, 5 Specifically,
hydrogels fabricated from natural polymers can increase cell adhesion, but the
complexity of the chemical structure can have unknown interactions with the adhered
cell.5, 7, 8 Synthetic substrates such as PA and PDMS are capable of achieving elastic
moduli of 0.1 to 1000 kPa and have the benefit of precise control of mechanics via
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crosslinking ratios.5 However, it has been observed that PA gels and PDMS require
surface modification to allow cell adhesion.2, 9-11
The co-polymer network of n-octyl methacrylate (nOM) and diethyleneglycol
dimethacrylate (DEGDMA) was chosen based on the proven biocompatibility as dental
restorative material.12, 13 Young et al. showed that an increase from 5 to 20 wt%
DEGDMA at 37°C corresponds to an increase in the storage modulus from 103 to 104.1
kPa.14 Initially, a trimethacrylate system was also investigated, using trimethylolpropane
trimethacrylate as the crosslinker. This system has also been shown to be biocompatible
and has an increase in storage modulus with increase in crosslinker content. The
trimethacrylate system was not chosen for this platform as the 3.5 wt% crosslinker
materials have a storage modulus nearly an order of magnitude larger than the 5 wt%
dimethacrylate system.15 The much larger storage material modulus would limit the
trimethacrylate based system to the upper range of tissues. The use of these studies as the
basis for our work, the dimethacrylate system was chosen. The dimethacrylate system
offers a physiologically relevant moduli range and the ability to fabricate substrates that
are homogenous in the material properties.
The values of DEGDMA content were chosen based on the glass transition
temperatures determined by Young et al.16 It was observed that at approximately 33 wt%
DEGDMA that poly(nOM-co-DEGDMA) has a glass transition temperature of 37°C,
body temperature. Although the substrates were based on Young‘s poly(nOM-coDEGDMA), adaptations of the photoinitator and fabrication techniques were necessary
for poly(nOM-co-DEGDMA) substrates to be used as a cell culture platform. These
changes will have an impact on the properties of the resulting polymer substrate. For
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example the photoinitator was changed from 2,2-dimethoxy-2-phenylacetophenone
(DMPA) in the Young studies to IRGACURE 2959 in the current study. The change of
the photoinitator has an impact on the reaction kinetics and thus the final internal
structure of the polymer networks. The bulk material properties of compressive modulus
and glass transition temperature were tested to determine the range of achievable
modulus. The surfaces of these materials were evaluated to determine relative
hydrophobicty, chemical composition and topography across a single formulation as well
as between the different formulations. Finally, the polymer networks were verified as a
viable cell culture platform.

2. Materials and Methods
2.1. Substrate Fabrication
Substrates were polymerized from n-octyl methacrylate (nOM; Scientific Polymer
Products (SPP), Ontario, NY) and diethyleneglycol dimethacrylate (DEGDMA; SPP). nOctyl methacrylate and DEGDMA were received inhibited with monomethyl ether
hydroquinone (MEHQ) and hydroquinone (HQ), respectively. The radical inhibitor was
removed with HQ/MEHQ removal columns (SPP) immediately before use. The
photoinitiator used for these studies was 1-[4-(2-hydroxyethoxy)phenyl]-2-hydroxy-2methylpropan-1-one (IRGACURE 2959, Ciba, Florham Park, NJ). Four substrate
formulations were fabricated with 3, 19, 25 or 33 wt% DEGDMA and 0.25 wt%
IRGACURE 2959, with the remaining being nOM.
Monomers and radical initiator were added to a glass vial and heated to slightly
above room temperature to allow the IRGACURE 2959 to dissolve. The reaction mixture
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was allowed to stir overnight at room temperature. The reaction mixture was poured into
glass molds, 3 x 5 x 0.1 cm, and polymerized in a UV crosslinking box (CL-1000, UVP,
Upland, CA) for 300 minutes with a maximum wavelength emission at 365 nm and
exposure energy of 999.9 mJ/cm2. Substrates were removed from molds by sonication in
ethanol (200 proof, Fisher Scientific, Waltham, MA). Circular samples of diameter 6 mm
were cut out of the cured sheet using a biopsy punch (96-1125, Sklar, West Chester, PA).
These circular samples were used to determine glass transition temperature (Tg), contact
angle measurements, X-ray photoelectron spectroscopy (XPS), atomic force microscopy
(AFM), protein adsorption and biocompatibility. Samples intended for compressive
modulus testing were fabricated in glass vials with an inner diameter of 6 mm. To obtain
a 2:1 height to diameter ratio the crosslinked cylindrical samples were cut to a length of
12 mm with a wet saw (TechCut 5™, Allied High Tech Products Inc., Rancho
Dominguez, CA). Before testing all samples were submerged in 200 proof ethanol
(Fisher) for 48 hours, degassed overnight under vacuum, and submerged in 18 MΩ water
(Synergy UV, Millipore, Billerica, MA) for 1 week.

2.2. Bulk Compressive Modulus
Compressive modulus of the bulk material was determined for the four formulations
(n=5) using an Instron (5500R, Instron, Norwood, MA) following ASTM 695 – 02a. The
experiment was performed using MTS ReNew software (Eden Prairie, MN). Stress –
strain curves were analyzed in the linear region (5 – 20% strain) using Microsoft Excel
(Microsoft Croporation, Redmond, WA) to determine sample modulus.
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2.3. Glass Transition Temperature (Tg)
The Tg was measured using differential scanning calorimetry (DSC Q100, TA
Instruments, New Castle, DE). Material samples were cut down from the 6 mm disks to 1
mm2 squares to fit in the sample pans (900779.901, TA Instruments). The samples were
heated from -50°C to 150°C at a rate of 10°C/min for 3 cycles. The Tg calculated from
the DSC heat flow trace from the midpoint of step function using the instrument software
(Universal Analysis, TA Instruments).

2.4. Contact Angle Measurement
Samples were dried under vacuum overnight. Contact angles were determined using
the sessile drop technique on a goniometer (Model 100-00-115, ramé-hart Inc., Netcong,
NJ). Briefly, 3 μL of ultrapure water was pipetted onto the center of the sample surface
to avoid edge effects. The contact angle between the water droplet and the sample
surface was determined using the DROPimage Standard program (ramé-hart). The
contact angles were measured immediately after drop formation to minimize the effect of
dynamic surface wetting and evaporation. Four samples of each formulation were tested
with one drop per sample and three measurements per drop.

2.5. X-ray Photoelectron Spectroscopy (XPS)
XPS survey and high resolution spectra were obtained using Kratos Axis Ultra
spectrometer with a monochromatic Al K(α) (1486.6 eV) source at 225W. Highresolution spectra of carbon and oxygen were obtained for two areas for each sample.
Survey spectra were obtained at pass energy 80 eV and high-resolution spectra at pass

33

energy 20 eV. Base pressure was less than 5 x 10-9 Torr. Charge compensation was
accomplished using low energy electrons. Linear background was used for elemental
quantification of C1s and O1s spectra. Quantification utilized sensitivity factors provided
by the manufacturer. All the spectra were charge referenced to the aliphatic carbon at 285
eV. Curve fitting was carried out using individual peaks of constrained width, position
and 70% Gaussian/30% Lorentzian line shape.

2.6. Atomic Force Microscopy (AFM)
Samples for the AFM were incubated with 5 mL ethanol while sonicated for 2
minutes. The ethanol wash was followed by rinsing in 5 mL of deionized H2O (dH2O).
The cleaned samples were mounted on a glass coverslip using silicon vacuum grease and
inserted in a liquid cell (BioHeater Closed Fluid Cell, Asylum Research, Santa Barbara,
CA). The fluid cell was mounted on the AFM instrument (MFP-3D Version 050810,
Asylum Research (AR), Santa Barbara, CA) and filled with dH2O. The liquid cell was
heated to 37°C (AFM Environmental Controller, AR). Surface scanning was performed
at 2.50 µm per second at 0.2 Hz with a 40 nm radius cantilever tip (TR400PB, Olympus,
Center Valley, PA). Scans were analyzed using Igor Pro (MFP-3D, Asylum Research).

2.7. Total Protein Adsorption
Four substrates of each of the four formulations were mounted onto the bottom of flat
bottom 96 well plate (3370, Corning Inc., Corning, NY) with a small amount of silica
vacuum grease. The loaded plate was placed under UV (NU-430-600, Nuaire,
Plymouth, MN) radiation for 30 min to sterilize the plate. Each substrate was incubated
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with 2 mg/mL bovine serum albumin (BSA, A9418-5G, Sigma-Aldrich, St, Louis, MO)
in 1X phosphate buffer saline (PBS, C001N22, Thomas Scientific, Swedesboro, NJ) for
45 minutes at 37°C. The BSA/PBS solution was removed, and substrates were washed
three times with 200µL of PBS to remove non-adsorbed proteins. Substrates were then
incubated in 150µL 2% SDS solution overnight at 37°C. The 2% SDS was removed from
the substrates and placed in a black walled clear bottom plate (3370, Corning), and
protein content determined with the Micro BCA Protein Assay Kit (23235, Thermo
Scientific, Fremont, CA) as per the manufacturers‘ instructions, and compared to a BSA
standard curve. The analysis of the assay was performed using the SpectraMax M2
Microplate Reader (Molecular Devices, Sunnyvale, CA) at 562nm.

2.8. Cellular Seeding
The murine cell line MC3T3-E1 (CRL-2593, ATCC, Manassas, VA) was used as a
model cell line for all cell studies. All tissue culture solutions were purchased from
Fisher Scientific. Cells were cultured in 75 cm2 tissue culture polystyrene (TCPS)
medium consisting of MEM alpha modification media (1X) supplemented with 10%
(v/v) fetal bovine serum (FBS), 1% (v/v) penicillin/streptomycin (P/S), and 1% (v/v)
fungizone at 37°C and 5.0% carbon dioxide. At ~80% confluence, cells were rinsed with
2 mL Dulbecco‘s phosphate buffered solution (DPBS). Cells were lifted with 2 mL of
0.25% (w/v) trypsin incubated at 37°C for 15 minutes. The cell solution was transferred
to two micro centrifuge tubes and centrifuged at 2000 rpm for 5 minutes. The
supernatants were removed and the pelleted cells were resuspended in 2 mL of fresh
culture media, the cell solutions were recombined. Cell concentrations were determined
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using a hemocytometer (1483, Hausser Scientific, Horsham, PA). Four samples of each
substrate formulation were loaded into a flat bottom non-tissue culture polystyrene 96
well plates (3370,Corning, Lowell, MA). Samples were covered with 200 µL of ultra
pure water and sterilized through exposure to UV radiation (Nuaire) overnight. After
removal of the water, surfaces were seeded with MC3T3-E1 cells at a density of 25,000
cells/cm2.

2.9. Cellular Attachment and Viability
Cellular attachment and viability were assessed after 6 and 96 hours, respectively,
using the Live/Dead® Cell Viability Assay (Invitrogen, Carlsbad, CA) as per the
manufacturer‘s instructions. Four samples of each substrate formulation were used per
time point. Live and dead cell controls consisted of cells seeded at the same density on
regular (non-tissue culture treated) polystyrene 96 well plates (3370, Corning). Dead
controls were incubated with 100 µL of 70% methanol/30% water for 30 minutes prior to
staining. All samples were incubated with 100 µL of 4 µM ethidium homodimer-1 (ex
495nm/em 515nm) and 1 µM calcein AM (ex 495nm/em 635nm) for one hour, thereby
staining the live cells green and dead cells red. The fluorescently labeled cells were
imaged on an inverted microscope (Eclipse TS-100, Nikon, Melville, NY) with a
mercury light source (X-Cite Series 120, Lumen Dynamics, Mississauga, Ontario).
Images were captured with a 14.2 Color Mosaic camera and processed using Spot
software (Diagnostic Instruments Inc. Sterling Heights, MI).
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2.10.

Statistical Analysis

Compressive modulus and protein adsorption results were analyzed using the
Kruskal-Wallis one-way nonparametric analysis of variance (ANOVA) with values of p
< 0.05 considered statistically significant. Contact angle measurements were compared
for significance using a Friedman Test (nonparametric repeated measures ANOVA) with
values of p < 0.05 considered statistically significant. All analysis was done with InStat 3
(GraphPad Software, La Jolla, CA).

3. Results
3.1. Bulk Compressive Modulus
The uniaxial compressive modulus was determined from the slope of the linear region
of the stress-strain curves.17 Compressive moduli of all four formulations (3, 19, 25 and
33 wt% DEGDMA) are presented in Figure 2-1. All formulations were found to be
significantly different with p < 0.01.
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Figure 2-1. Compressive modulus for the four formulations studied, 3, 19, 25 and 33 wt% DEGDMA substrates.
Slight increase or decrease in DEGDMA content can be used to achieve a tunable material modulus. n=5, † p < 0.01
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3.2. Glass Transition Temperature
Glass transition temperatures (Tg) for the four formulations are shown in Figure 2-2.
The Tg was determined from the heat flow traces between -50 and 150°C heated at a rate
of 10°C/min. The midpoint of the step functions observed from the heat flow traces were
used to establish the Tg. The increase in Tg with the increase of DEGDMA content is
expected as an increase of crosslinking density is proportional to the increase in
crosslinker content. This phenomenon is due to the decrease in the degrees of freedom of
each chain. Figure 2-2 demonstrates the Tg increase from -7 to 53°C between the 3 and 33
wt% DEGDMA substrates.
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Figure 2-2. Glass transition temperatures (Tg) for the four formulations of varying DEGDMA content substrates
tested. The Tg varies proportionally with the measured compressive modulus.
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3.3. Contact Angle Measurement
Using the Sessile drop technique, the water contact angles were used to determine the
surface wettabilty with a 3 µL drop of 18 MΩ water. Contact angle is a simple method to
approximate solid-vapor and solid-liquid interfacial tensions by measuring the tangent
angle where the three phases intersect.18 Contact angles for 3, 19, 25 and 33 wt%
DEGDMA substrate formulations are presented in Figure 2-3. No statistical difference
was found across all of the four different substrate formulations. Consistent contact angle
indicates that the surface energetics and topography are similar between different
material formulations. The similarity in contact angle suggests that the amount of protein
adsorption and conformation will be comparable across the different formulations.
100
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Figure 2-3. Sessile drop contact angle measurements for the four substrate formulations. No statistical difference
between formulations was observed, indicating consistent surface wettability/hydrophobicity across the range of
formulations. n=4 for each formulation.
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3.4. X-ray photoelectron spectroscopy
Quantification of the elemental composition and functional groups was performed
using XPS. The position of the peak (i.e., binding energy) and the peak intensity were
used to identify surface elemental composition, the chemical bond environment, and
quantity of each of the DEGDMA formulations. Solid samples of 3 and 33 wt%
DEGDMA formulations were analyzed to validate that the differences between the
substrates chemical surface was minimal. For each sample, two spots were analyzed to
confirm consistency across a single formulation. Heterogeneities in the material were
observed with the initial material evaluation by Young et al., primarily believed to be due
to cyclization of the polymer network as the amount of crosslinking agent was increased
past a critical point.19 Surface characterization was performed at multiple spots on the
surface to verify that these cyclizations would not have a negative impact on poly(nOMco-DEGDMA) ability to be used for cell culture.. Several surface analysis techniques
were employed to verify homogenous surfaces on a single substrate and across multiple
substrate formulations.
The elemental compositions of the substrates are shown in Table 2-1. Briefly, the
compositions of both formulations are nearly identical (79.2% C and 16.4% O for the 3%
DEGDMA formulation; 80.7% C and 17.4% O for the 33wt% DEGDMA formulation).
The variation between samples is well within the experimental error of the technique.20-22
From this data, the ratio of C/O was calculated and compared to that of the predicted by
the stoichiometry of the monomers. The observed ratio of C/O of the 33wt% DEGDMA
formulation (4.6) is nearly identical to the value predicted by stoichiometry of the
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monomers (4.3). The 3wt% DEGDMA formulation C/O ratio differs slightly from the
expected value (4.7 to 5.7, respectively); this difference is most likely due to the presence
of hydroxyl groups on the surface from incomplete conversion of free radicals during
polymerization.

Table 2-1. Elemental composition of the maximum and minimum DEGDMA content substrates made determined by
XPS analysis. Values represent the relative atomic percentage of each species present on the surface averaged from
two locations. Trace amounts of (<1%) nitrogen and silicon (<4%) was also detected.

3% DEGDMA
Experimental
3% DEGDMA
Stoichiometric
33% DEGDMA
Experimental
33% DEGDMA
Stoichiometric

C 1s

O 1s

C / O Ratio

79.2

16.4

4.7

85

15

5.7

80.7

17.4

4.6

81

19

4.3

In addition to obtaining elemental information, high-resolution spectra were obtained
for carbon and oxygen to observe the chemical species of these elements. High-resolution
O1s spectra in Figure 2-4B show similar shapes between the 3 (top) and 33 (bottom) wt%
DEGDMA formulations. Table 2-2 contains the oxygen binding environment
quantification values. Peak assignments were as follows: O=C, 532.3 eV; C-O-C, 533.9
eV; O-(C=O), 534.4 eV; O-H, 536 eV.23 The location of the peak fits for the α-oxygen
(O-(C=O)) and the ether (C-O-C) are within 1 eV, which is below the resolution of the
instrument. [30% C-O-C and 24% O-(C=O) for 3 wt% DEGDMA, 31% C-O-C and 23%
O-(C=O) for 33 wt% DEGDMA]. It is necessary to combine the two quantification
values; from this adjusted data the ratio of ester to ether was calculated. For both the 3
and 33 wt% DEGDMA formulations the ratio of ester to ether functionalities are almost
identical between the experimental and the values predicted by the stoichiometry of the
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monomers (0.6 to 1.0 for 3wt% DEGDMA, 0.7 to 0.9 for 33wt% DEGDMA). The
observed peak for hydroxyl (O-H, 536 eV) is most likely due to oxidization at the surface
from incomplete conversion of free radicals from the polymerization.

Figure 2-4. Representative high-resolution scans from 3 (top) and 33 (bottom) wt% DEGDMA formulations for C1s
(left) and O1s (right). The surface reproducibility is confirmed by the C1s high-resolution scans (A) of the 3 and 33
wt% DEGDMA substrates. The O1s high-resolution spectra (B) for 3 and 33 wt% DEGDMA demonstrate similar peak
shapes between the two formulations.

The high-resolution C1s spectra (Figure 2-4A) have similar shapes between the 3
(top) and 33 (bottom) wt% DEGDMA formulations. The peak assignments for the carbon
high resolution peak are as follows: aliphatic carbon, 285 eV; C-(C=O)-O, 285.7 eV; CO, 286.8 eV, C=O, 288.8 eV.23 As with the O1s spectra, the peaks for the α-carbon (C(C=O)-O, 285.7 eV) and the aliphatic carbons (C-C, 285 eV) are separated by less than 1
eV at the peak maxima. The separation necessitates the combination of the peak fit
parameters (46% C-C and 23% C-(C=O)-O for the 3 wt% DEGDMA formulation; 45%
C-C and 25% C-(C=O)-O for the 3 wt% DEGDMA formulation) and is shown as a
calculated value in Table 2-3 (69% and 70% for 3% and 33% DEGDMA formulation,
respectively). The adjusted value for the aliphatic carbon was used to calculate the ratio
of C-C/C-O and C-C/C=O. The variation between the C-C/C-O value for the 3 and 33
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wt% DEGDMA formulations (3.3 and 3.6, respectively) is an excellent demonstration of
the limited variation between the two extremes of material rigidity.
Table 2-2. High-resolution spectra of oxygen quantification. Oxygen binding environment of 3 and 33 wt% DEGDMA
content substrates. Values represent the relative percent of each species present on the surface averaged from two
different locations on the surface. The experimental values are shows for 3 and 33 wt% DEGDMA for each
formulation.

3% DEGDMA
Experimental
3% DEGDMA
Stoichiometric
33% DEGDMA
Experimental
33% DEGDMA
Stoichiometric

O=C
532.3

C-O-C
533.9

O-(C=O)
534.4

O-H
536

C-O-C + O-(C=O)

O=C / O-C

33

30

24

13

54

0.6

50

1

49

-

50

1.0

35

31

23

24

54

0.7

47

6

47

-

53

0.9

Table 2-3. High-resolution spectra of carbon quantification. Carbon binding environment of 3 wt% and 33 wt%
DEGDMA content substrates. Values represent the relative percent of each species present on the surface averaged
from two different locations on the the surface. The experimental values are shows for 3 wt% and 33 wt%
DEGDMA for each formulation.

3% DEGDMA
Experimental
3% DEGDMA
Stoichiometric
33% DEGDMA
Experimental
33% DEGDMA
Stoichiometric

C-C
285.0

C-(C=O)-O
285.7

C-O
286.8

C=O
288.8

C-C + C-(C=O)-O

C-C/ C-O

C-C/ C=O

46

23

21

7

69

3.3

9.8

74

8

8

8

82

10.3

10.3

45

25

19

12

70

3.6

5.8

66

10

12

10

76

6.3

7.6

3.5. Atomic Force Microscopy
To ensure consistent surface topography over the range of substrate formulations,
AFM was used to map the substrate‘s topography at three different locations on each of
the lowest and highest content DEGDMA formulations. Figure 2-5 presents
representative AFM micrographs of the substrate‘s surface for 3 and 33 wt% DEGDMA
(Figure 2-5A & B, respectively). Amorphous surface features on the order of 0.5µm in
diameter are can be observed on both formulations. The AFM scans were also used to
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quantify the surface roughness. Surface roughness was evaluated at the three random
spots on each substrate. Roughness was calculated from the three 50 x 50 µm area,
approximating the surface area occupied by a single mammalian cell. The root mean
squared roughness (Rrms) values were measured to be 14 ± 1 nm and 17 ± 6 nm for 3 and
33 wt% DEGDMA formulations, respectively.

Figure 2-5. Representive atomic force microscopy scans of (A) 3% DEGDMA, and (B) 33% DEGDMA. Three 50 x 50
µm AFM scans were performed on each formulation to verify consistent surface topography across each sample.
The average Rrms was calculated from the three a reas of each formulation and found to 14±1 and 17±6 nm for 3
and 33 wt% DEGDMA formulations, respectively. Similar surface features are observed between the upper and
lower limit of DEGDMA content substrates that are imparted to the polymer surface from the surface of quartz
mold.

3.6. Total Protein Adsorption
Bovine serum albumin (BSA) was chosen as a model protein to demonstrate
consistent protein adsorption. The bicinchoninic acid assay (BCA) is a colorimetric
protein assay that detects cuprous ions (+1) generated from cupric ions (+2) by reduction
in the presences of proteins in an alkaline environment.24 The BCA assay was selected
over the use of radiolabeling followed by scintillation counting for the long term stability
44

of the BCA while still maintaining a sufficiently low detection limit of 0.5μg/mL.24
Figure 2-6 shows the quantities of BSA that were adsorbed onto the surfaces of the
different formulations of substrates at 37°C for 45 minutes using initial protein
concentrations of 2 mg/mL. The amounts of protein adsorbed onto the substrate surfaces
ranged from 17.8±1.8 to 19.7±1.7 µg/cm2. No statistically significant difference was
found between the four different substrate formulations. This confirms the results as
predicted by water contact angle, XPS and AFM that protein adsorption is not affected by
the rigidity of the substrate surface.

Concentration of BSA (ug/cm 2 )

25

20

15

10

5

0

3% DEGDMA

19% DEGDMA

25% DEGDMA

33% DEGDMA

Figure 2-6. Adsorption of BSA onto the four different substrate formulations after 45 minute incubation at an intital
protein concentration of 2 mg/mL measured with Micro BCA assay. No statistically significant difference was found
between the different formulations. n=4.
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3.7. Cell Attachment and Viability
A murine pre-osteoblastic cell line (MC3T3-E1) was used to demonstrate cellular
attachment and proliferation of a monolayer cell culture on all four formulations. Viable
cells were stained green and cells undergoing cell death were stained red. Viable cells
were seen adhered to all formulations six hours after seeding (Figure 2-7 A-D). Figure 27 E-H show representative images of stained cells 96 hours after initial seeding on
substrates. All formulations show an increase in green fluorescence indicating an increase
in the number of viable cells.

Figure 2-7. MC3T3-E1 cell line visualized with Live/Dead® fluorescence staining. Green = live, Red = dead, cells
seeded at 25,000 cells/cm2. Live and dead images false pseudo colored and then merged into a single image using
Adobe Photoshop CS2. Images were obtained at 6 hours post cell sedding (top row) and 96 hours post seeding
(bottom row). A) 3 wt% DEGDMA 6hr, B) 19 wt% DEGDMA 6hr, C) 25 wt% DEGDMA 6hr, D) 33 wt% DEGDMA 6hr, E)
3 wt% DEGDMA 96hr, F) 19 wt% DEGDMA 96hr, G) 25 wt% DEGDMA 96hr, H) 33 wt% DEGDMA 96hr. Scale Bar =
100 µm in all images.
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4. Discussion
The uniaxial compressive modulus exhibited a two order of magnitude increase in the
materials compressive modulus, from 25 ± 2 to 4700 ± 300 kPa, with an increase of 3 to
33 wt% DEGDMA content (Figure 2-1). The lower limit of 3 wt% DEGDMA content
was selected to obtain the softest stable free standing substrate. Research by Kannurpatti
et al. showed that the inner two formulations (19 and 25 wt% DEGDMA) bounds a
critical point for poly(nOM-co-DEGDMA). These bounding points designate a change in
the dominating property controlling the bulk modulus.19 For the lower two substrate
formulations, 3 and 19 wt% DEGDMA, there is a decrease in the degrees of freedom of
the polymer chains due to an increase in the crosslinking density. The polymer backbone
is primarily nOM with DEGDMA crosslinks. While in the upper two formulations, 25
and 33 wt% DEGDMA, the mechanical properties are controlled by co-polymerization.
The co-polymerization effect is purely based on the stiffness of the polymer backbones;
which is based on the monomers and the fractions in which they are present.16, 19, 25 Copolymerization dominates when DEGDMA is no longer just a crosslink between polymer
chains of nOM, but is a repeat unit in the polymer backbone. This is further supported by
the work of Young et al., as the plot of polymer molecular weight between crosslinks and
DEGDMA content asymptotically levels out.16 As seen in Figure 2-1, the modulus of the
3 and 19 wt% DEGDMA substrates increases from 25 ± 2 to 920 ± 60 kPa. The next
jump from 19 to 25 wt% DEGDMA shows a ~3000 kPa increase in the compressive
modulus crossing over the transition between the ‗crosslinking effect‘ and the ‗copolymerization effect‘ of poly(nOM-co-DEGDMA). An increase of DEGDMA content
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to 33 wt% DEGDMA results in an increase of 600 kPa from the 25 wt% DEGDMA
substrate and gives this studies highest achievable modulus of 4700 ±300 kPa.
A higher glass transition temperature equates to a lower molecular weight between
crosslinks and an increase in modulus. The change in the bulk material properties is due
to the decrease in the degree of freedom of the chains between crosslinks.14 The values of
DEGDMA content were chosen based on the glass transition temperatures determined by
Young et al.16 The Tg was observed to be 37°C with approximately 33 wt% DEGDMA
body temperature.
Substrate surface evaluation was begun by measuring water contact angles in sessile
drop mode. Contact angles are largely dictated by relative surface hydrophobicity, but
can also be impacted by the topography and chemical functional groups presented at the
surface of the substrate.18 A consistent angle from the range of formulations indicates
similarities of topography and chemical features on all of the substrates. The contact
angles measured show no statistical difference across the range of DEGDMA
formulations (Figure 2-3), with all measured to be approximately 90°. The consistency in
the surface energetics gives indication that biomolecular adsorption onto the surface will
be similar for all of the substrates. To achieve a quantified understanding of the substrates
surface it was necessary to independently interrogate the surface topography and
chemical features.
Quantification of the chemical surface composition by XPS provides the elemental
and chemical binding environment present on the substrate‘s surface. Elemental
composition was observed at two different locations on each formulation, (Table 2-1)
both formulations have similar elemental composition (79.2% C, 16.4% O for 3%
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DEGDMA and 80.7% C, 17.4% O for 33 wt% DEGDMA). The carbon-oxygen ratio for
the 3wt% DEGDMA formulation shows a higher than predicted amount of oxygen
present on the surface (4.7 experimental to 5.7 stoichiometry). Possible explanations for
this could be the polymer presents the ester and ether side groups on the surface while
burying the alkyl carbon or an additional oxygen functional group is on the surface. The
latter of these two possible explanations is supported by the detection of O-H species at
536 eV (Figure 2-4B). It is likely that the incomplete conversion of the free radicals for
polymerization produce an alcohol terminal when exposed to air. Ratios of ether to ester
functional groups allowed evaluation independently from the peak at 356 eV. The ratios
are close to that of the predicted values (0.6 to 1.0 for the 3% DEGDMA and 0.7 to 0.9
for the 33% DEGDMA formulation), Table 2-2. The increased amount of ether groups
compared to the esters is seen at each of the separate analysis points. The most likely
explanation for the difference is the presence of polydimethylsiloxane (PDMS). The
silicon-oxygen bond present in the backbone of PDMS can contribute electrons from the
oxygen with similar binding energy to carbon-oxygen bonds. The trace amounts of
PDMS can be transferred to the substrate by handling with tweezers and drying the
samples in a vacuum oven that may have been used for PDMS gas evacuation. The
presence of PDMS would increase the amount of ether (peak at 534 eV) observed from
the O1s high-resolution spectra curve fits. Further analysis of the sample using highresolution C1s spectra showed similar amounts of carbon in the specified chemical
environments between the different formulations in Table 2-3 (69% and 70% C-C for 3
and 33 %DEGDMA, respectively). The ratios of carbon binding states are not near the
values predicted my stoichiometric analysis. This also was likely due to the presence of
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trace amounts of PDMS on the surface. The silicon-carbon binding environment for
carbon can possibly alter the amounts of ether and aliphatic carbon observed in the
spectra. Even with the differences between the experimental values and the predicted
values, analysis shows the surface chemistry varies little across each formulation as well
as across the 3 and 33 wt% DEGDMA substrates (3.3 to 3.6 C-C/C-O for 3 and 33 %
DEGDMA, respectively). The two extremes of formulation were evaluated first; we
found no significant difference between the two. This did not require the further use of
the technique for surface evaluation of the two intermediate formulations.
Consistent surface topography was confirmed using AFM. This method was chosen
as it allows for the assessment of the micro sized features with no need to further modify
the surface for evaluation. All AFM scans were performed in a liquid cell filled with
deionized water at 37°C. Heated liquid AFM was performed to ensure that the use of
environmental conditions consistent with cell culture conditions did not alter the surface.
As with XPS analysis, the 3 and 33 wt% DEGDMA formulations were analyzed to verify
that the substrates with the most drastic difference in modulus had similar topography.
Surface features observed with the AFM in the liquid cell were comparable with scanning
electron microscopy images (not shown) of dried substrates, suggesting that the
substrates are not undergoing swelling or other alteration when heated and wetted. The
observed features were amorphous and random, from the nanometer to millimeter length
scales (Figure 2-5). The surface roughness was measured using AFM and calculated
through Rrms for three areas on each formulation. It was observed that the similar features
of randomly spaced high points without consistent height were seen on the AFM scans of
the different formulations. Roughness values were seen below 20 nm with standard
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deviation less than 6 nm obtained for the 3 and 33 wt% DEGDMA formulations. This
data shows that the surface topography are consistent across a single sample, as well as
between the different formulations. It is believed that any of the surface topography
observed was imprinted on the substrates because of the mold materials surface
topography.
Protein adsorption on a surface is dependent on the properties of electrostatic
interactions, and dictates how cells will interact with a surface.26-29 Bovine serum
albumin was chosen as a model protein because the globular protein will adsorb onto
surfaces and based on the electrostatics of the substrate will induce structural changes in
the BSA.30-32 Relatively hydrophobic substrates of polystyrene (water sessile drop contact
angle ~85°) were found to form 58% of a complete protein monolayer.32 Conversely
hydrophilic substrates form 95% of a complete protein monolayer.32 The difference in the
amount of protein adsorbed is due to the differences in the conformation of the adsorbed
BSA. The hydrophobic substrates attract the non-polar regions of BSA molecules,
inducing denaturation of the protein.31 Hydrophilic substrates allow for retention of the
native structure increasing the packing density.31 The difference in the amount of protein
adsorbed can be used to infer the conformation of the protein when adsorbed to the
surface. The drastic difference between BSA adsorbed on varying substrates allows for a
greater sensitivity when determining protein substrate interactions, over proteins (i.e.
ECM components) that have secondary and tertiary structure stabilization by covalent
bonding.
The adsorption of BSA on nOM/DEGDMA (water sessile drop contact angle ~90°)
should be similar to that of the polystyrene suggesting the formation of partial protein
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monolayers. Measurements of the model protein BSA adsorption onto the four different
formulations demonstrated that there is no statistically significant difference between the
amounts of protein adsorbed (17.8±1.8 to 19.7±1.7 µg/cm2). This implies that when
substrates are formed from varying ratios of nOM/DEGDMA and incubated with cell
culture media that contain proteins (i.e. FBS), similar quantities of those proteins will
adsorb to the surface.
Murine MC3T3-E1 cells were chosen to demonstrate that this material as fabricated is
not only biocompatible, but supports cell attachment and proliferation. This cell line was
chosen because it is a well studied cell line, with many substrate interactions already
understood.33 Live/Dead® staining allowed the simultaneous testing of cytotoxic effects
as well as observation of cell attachment and proliferation. Cell attachment was observed
six hours post seeding across all four sample formulations A separate sample set was
stained after 96 hours. The later time point confirmed that cells were still adhered to the
surface and proliferated, corresponding with an increase in the fluorescence signal. The
preferential attachment of 3T3s to a stiffer material has been demonstrated by Lo and
Pelham.9, 33 This can be generally seen across the different substrate formulations (Figure
2-7), as it appears the cell density increases with the increase of material modulus.

5. Conclusion
Herein we have successfully fabricated substrates by photopolymerization of nOM
and DEGDMA. The substrates‘ mechanical properties are independently varied without
significant impact on the topography or chemical composition of the surface. The
variation of previous substrate‘s mechanical properties induced changes in the surface
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properties, making them non-ideal for use as model systems. Rather than continue to
modify existing materials with limited success, we developed a synthetic culture substrate
to fill these needs. The amount of DEGDMA was varied to produce substrates with
compressive modulus over three orders of magnitude, ranging from ~20 to 5000 kPa. The
relative surface hydrophobicity, elemental/functional composition and topography were
shown to be extremely consistent across a single substrate and between the different
formulations. Maintenance of the surface physical and chemical features enables for the
systematic evaluation of the effects of material stiffness on cellular functions. This model
platform can be used to screen polymer formulations with a large range of moduli while
maintaining consistent surface (chemistry, topography and relative hydrophobicty). This
will allow for the systematic evaluation in order to identify appropriate rigidity for the
engineering and design of biomaterials for aortic valve tissue engineering. Additionally,
this platform will find utility in studies of cellular biology associated with initiation and
progression of diseases which are characterized by a stiffening of the tissue, including
calcification of the heart valve,34 liver fibrosis,35 and many cancers.2
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1. Introduction
The limitations of current aortic heart valve (AV) replacement therapies necessitate
the development of a living biologic replacement.1 Neither mechanical nor decellularized
biological valve replacements offer a patient an unimpeded lifestyle after therapy.2, 3
Decellularized biological valves are limited in functional lifetime, while synthetic valves
require anti-coagulants to reduce the risk of thrombosis.4 The goal of creating a tissue
engineered (TE) valve is to yield a cell populated construct that possess the capability to
integrate with surrounding tissues as well as grow and repair over time. In recent years, a
number of AV TE strategies employing both natural and synthetic scaffold materials with
different cell sources have been explored. To date, however, success has been limited in
the demanding position of the AV.1 The biggest restriction for developing TE
replacements has been an incomplete understanding of normal and pathological valve cell
biology.
The main cell types present in the AV are the valvular endothelial cells (VECs) and
valvular interstitial cells (VICs).5, 6 The VECs line the blood contacting surfaces and have
been implicated in the regulation of inflammation, thrombosis, and remolding through
cytokine release.7-9 The VICs are found throughout the valve and are a heterogeneous
population consisting of fibroblast-like, myofibroblasts, smooth muscle cell-like and in
disease osteoblastic-like cells.5, 10 The diverse behavior of VICs phenotypic expression,
extracellular matrix (ECM) production, apoptosis and contraction have been shown to be
influenced by environmental factors such as cytokines, growth factors and mechanical
factors.11-14
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VICs exist in a variety of phenotypes in vivo, the patterns of which vary spatially in
the valve as well as temporally during development, wound repair and disease.15 In the
adult AV 3 primary VIC phenotypes have been identified, quiescent (qVIC), activated
(aVIC), and, in disease the osteoblastic (obVIC).16 Changes in the combination of
mechanical stresses and soluble factors have been shown to mediate the transition of the
VICs between the phenotypes.17-19 For example, aVICs predominate during periods of
high ECM production during valve development and wound healing, marked by
expression of α-smooth muscle actin (αSMA).20 On the other hand, qVICs dominate
during healthy valve functions secreting low levels of ECM components.3, 21 Finally, the
obVICs have been associated with valve pathologies and calcification that results in
stiffening of the tissue, marked by expression of αSMA and core binding factor-1 (CBFa1).14, 16, 22 Of the three different phenotypes, the aVIC is desired for tissue engineering
applications for the high rates of proliferation and ECM turnover.16 By presenting the
VICs with the appropriate physical cues, it should induce the aVIC phenotype and ECM
synthesis in vitro.
When a healthy valve becomes diseased, there is commonly a stiffening of the tissue
and formation of calcified tissue.22 The change in the tissue compliance associated with
disease progression has peaked researchers‘ interest in the effects of substrate rigidity on
VIC phenotypic expression. To conduct these experiments, a number of natural and
synthetic materials have been employed. Natural materials have been used by varying
crosslinking density, thickness, and mounting to achieve a model material with varied
stiffness.23, 24 However, natural materials are inherently bioactive and may therefore
transmit additional signals to the cells not associated with the substrate mechanics.25
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Synthetic materials used previously for rigidity studies include polyethylene glycol
(PEG), polyacrylamide (PA), and polydimethylsiloxane (PDMS). These materials are
limited in application because of their small range of acheivable moduli and/or surface
instabilities.17, 25-29 The previsouly characterized dental cement co-polymer network of noctyl methacrylate (nOM) and diethylene glycol dimethacrylate (DEGDMA) has recently
been shown in our laboratory to be an in vitro cell culture substrate which possesses a
wide range of moduli with minimal variation in surface properties.30-32
The work presented here focuses on the isolated impact of substrate rigidity on the
cellular functions of the VICs. While a few published studies have examined the
differences in substrate rigidities on VIC cellular functions, they have been limited
because the models used bioactive surfaces, providing additional signals to the VICs. 10, 24
Previous studies have used fibronectin, fibrin, and collagen to functionalize a substrates
for cell adhesion.14, 24 The varied substrata moduli of these studies was purposed to be the
major contributing factor to the cell response. However, the addition of the different
substrate functionalization proteins induced different cell responses independent of the
substrate moduli. Additionally, a number of studies used application of tension or
substrate thickness to increase substrate rigidity. These methods introduce structural
changes to the substrates.23, 24
The use of the nOM / DEGDMA substrates will allow for the independent evaluation
of substrate rigidity on VIC functions. Proliferation and phenotypic expression were
examined as a function of bulk substrate compressive modulus over the range of 20 to
5000 kPa. Major ECM components glycosaminoglycans (GAG), elastin and collagen-I
were also investigated to understand how substrate stiffness could be used to induce
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ECM production in vitro for TE applications without the application of additional growth
factors or cytokines. We hypothesize that softer materials stiffness similar to healthy AV
would promote the qVIC with low levels of proliferation and ECM secretion.
Additionally, it was hypothesized that as the material stiffness increased, the aVIC
phenotype will predominate with higher levels of proliferation and ECM secretion. To
evaluate our hypotheses VIC proliferation, phenotypic expression and ECM production
were examined on nOM / DEGDMA substrate with bulk moduli ranging from 20 to 5000
kPa.

2. Materials and Methods
2.1. Substrate Fabrication
Substrates were fabricated following the procedure described in detail of Chapter 2,
Section 2.1. Substrates were fabricated with monomers of n-octyl methacrylate (nOM;
Scientific Polymer Products (SPP), Ontario, NY) and diethyleneglycol dimethacrylate
(DEGDMA; SPP). Four substrate formulations were fabricated with 3, 19, 25 or 33 wt%
DEGDMA and 0.25 wt% IRGACURE 2959 (Ciba, Florham Park, NJ), with the
remaining being nOM, in glass molds for 300 minutes in a UV crosslinking box (CL1000, UVP, Upland, CA). Circular samples of diameter 6 mm were cut out of the cured
sheet using a biopsy punch (96-1125, Sklar, West Chester, PA), incubated in 200 proof
ethanol (Fisher Scientific, Waltham, MA) for 48 hours, degassed overnight under
vacuum, and submerged in 18 MΩ water (Synergy UV, Millipore, Billerica, MA) for 1
week.
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2.2. Nanoindentation
A Micro Materials NanoTest nanomechanical instrument (Platform 2, Version 1,
Wrexham, UK) was used to perform depth vs. load-controlled experiments on the
different nOM / DEGDMA material formulations (3, 19, 25 and 33 wt.% DEGDMA with
the remaining wt% being nOM) using a diamond tip Berkovich probe. All samples were
indented at a force that provided a contact depth of 4000 nm. Table 3-1 gives the loading
and unloading conditions for each formulation. Initial testing was performed to
determinate testing parameters that would ensure accurately measure the reduced
modulus to limit interference of plastic modulus, tip adhesion and sink-in.33-36 Each
formulation need test conditions because of the differences in the interaction between the
indentation tip and the materials. The linear range of the unloading curve was analyzed
with the Oliver-Pharr method to calculate the reduced modulus of each formulation.34
The Oliver Pharr method uses a plot of applied load, P, and penetration depth, h, to find
the slope of material unloading, . The unloading slope is then used with the projected
contact area of the tip, A, to calculate a materials reduced modulus, Er (Equation 3-1).33-36
The unloading curves between 100 - 60 % of maximum load were used for analysis. Ten
indentations per sample were performed.

Equation 3-1

dP
) 
Er  dh
2 A
(
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Table 3-1. Testing Parameters for Nanoindentation

3% DEGDMA
19% DEGDMA
25% DEGDMA
33% DEGDMA

Load / Unload
Rate (mN/s)
0.1
0.01
0.005
0.05

Hold
Time (s)
120
120
60
60

2.3. Primary Valvular Interstitial Cell Isolation
All tissue culture solutions and supplies were purchased from Fisher Scientific unless
otherwise specified. VICs were isolated following the procedure of Hanson and
Helgeson.37 Porcine aortic valve leaflets were surgically isolated from whole hearts
(Hormel Foods Corp., Austin, MN). Leaflets were cleaned in Dulbecco‘s phosphate
buffered saline (DPBS) with 1% (v/v) penicillin/streptomycin (P/S), followed by
digestion in a 250 units/mL collagenase solution (LS004174, Worthington Biochemical
Grp., Lakewood, NJ) digestion for 15 minutes at 37°C. Both sides of the leaflets were
mechanically scraped to remove the VEC layer. A second collagenase digestion was
performed for 1 hour at 37° C. Digested valve solutions were passed through a 70 µm
strainer to remove undigested valve pieces and the cell suspension solution was spun
down at 1,000 rpm for 10 minutes. The cell pellet was resuspended in Media 199 with
10% (v/v) fetal bovine serum (FBS), 1% (v/v) of P/S, 1% (v/v) fungizone (culture media)
and plated into T75 tissue culture polystyrene (TCPS) culture flasks. Cells were grown to
~70% confluency and lifted after incubation with a 2 mL of 0.25% (w/v) trypsin solution
at 37° C for 15 minutes. The cell/trypsin solution was transferred to a 15 mL conical tube
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and centrifuged at 2000 rpm for 3 minutes. The supernatant was removed and the pelleted
cells were resuspended in 5 mL of DPBS.
To remove any residual VECs, cell solutions were incubated with 50 µL of magnetic
bead suspension labeled with CD31 antibodies (Dynabead CD31, Invitrogen, Carslbad,
CA) in 15 mL conical tubes at 4° C for 30 minutes with occasional mixing. The tubes
were placed in a donut shaped separation magnet for 2 minutes, allowing VECs labeled
with magnetic beads to migrate to the sides of the tubes. The VIC solutions were
removed and placed in new conical tubes. VIC solutions were centrifuged at 2000 rpm
for 3 minutes and the supernatant was discarded. Pelleted cells were resuspended in
M199 media with 10% FBS (v/v), 10% dimethyl sulfoxide and cryogenically frozen until
use.

2.4. Cell Culture
Cryogenically frozen cells were allowed to thaw at room temperature and then
centrifuged at 2000 rpm for 3 minutes. The supernatant was removed and the pelleted
cells were resuspended in culture media (Media 199 with 10% (v/v) FBS, 1% (v/v) of
P/S, 1% (v/v) fungizone) and plated into T75 TCPS culture flasks. Cells were grown to
~80% confluency and lifted with 2 mL of 0.25% (w/v) trypsin incubated at 37° C for 15
minutes. The cell solution was transferred to a 15 mL conical tube and centrifuged at
2000 rpm for 3 minutes. The supernatant was removed and the pelleted cells were
resuspended in 2 mL of fresh culture media. Cell concentrations were determined using a
hemocytometer (1483, Hausser Scientific, Horsham, PA). Cell solutions were diluted
with media to obtain proper seeding densities for the variable serum, proliferation,
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phenotypic, sulfanted GAG production, and extra cellular matrix protein secretion
studies.

2.5. Variable Serum Conditions
Assay media was made to have the same composition as culture media without
phenol red indicator (1X MEM with 1% (v/v) of P/S, 1% (v/v) fungizone, 0.1 mg/mL LGlutamine with varying FBS compositions 10, 5, 3, 1, 0 % (v/v)). Assay media was
chosen without phenol red to use the same media that would be used with fluorescence
imaging in later experiments to reduce fluorescence background. Serum levels were
selected to compare previously published concentrations for proliferation and
morphology studies.14, 23, 38-41 VICs were seeded onto TCPS 24 well plates at 15,000
cells/cm2 with media containing one of the five different FBS concentrations. At days 1,
3, 7 and 9 assay media was removed and cells were treated with 0.5 mL of 0.25% (w/v)
trypsin for 15 minutes and wells were rinsed with 0.5 mL of DPBS solution. Cell solution
was diluted in 20 mL of DPBS and analyzed with a Coulter Counter (Z2, Beckman
Coulter, Miami, FL) between 10 and 22 µm. Four samples per media treatment group
were used.

2.6. Proliferation
Five samples of each substrate formulation were loaded into flat bottom non-TCPS 96
well plates (3370, Corning, Lowell, MA). Samples were covered with 200 µL of ultra
pure water and sterilized through exposure to UV radiation for 30 minutes. After removal
of the water, surfaces were seeded with VICs at a density of 15,000 cells/cm2 in assay
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media with 10% (v/v) FBS. Cellular proliferation was assessed after 1,2,4 and 7 days
using the CyQuant Direct Cell Proliferation Assay (Invitrogen, Carlsbad, CA) as per the
manufacturer‘s instructions. Cells were stained with the two part stain solution which
stains nucleic acids of all cells and suppresses the fluorescence of cells with
compromised membranes. The fluorescently labeled cells were imaged on an inverted
microscope (Eclipse TS-100, Nikon, Melville, NY) with a mercury light source (X-Cite
Series 120, Lumen Dynamics, Mississauga, Ontario). One 10x magnification image per
sample was captured with a 14.2 Color Mosaic camera (Diagnostic Instruments Inc.
Sterling Heights, MI) and processed using Spot software (Diagnostic Instruments Inc).
Automated image analysis to determine cell numbers (automated cell counting) was
performed with Cell Profiler software (Broad Institute, Cambridge, MA).
Following fluorescent imaging, cells were lifted using a 0.25% (w/v) trypsin solution
with a 30 minute incubation. Cell/trypsin solutions were retained and wells were washed
with 100 µL of DPBS to remove any remaining adherent cells. Cell/trypsin and wash
solutions were combined for analysis by flow cytometry (C6, Accuri Cytometers, Ann
Arbor, MI). Forward and side scatter gates were set to exclude debris and 30 µL of cell
suspension was passed through the cytometer. The data was analyzed with FCS Express
software (Version 4, De Novo, Los Angeles, CA). The gating for flow cytometry was
determined using a control experiment comparing stained VICs treated with 70% v/v
methanol/water with untreated VICs, Appendix Figure 3-11.
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2.7. Immunocytochemistry (ICC) for Phenotypic and ECM Protein Production
Three samples of each substrate formulation were loaded into a flat bottom non-tissue
culture polystyrene 96 well plates (3370, Corning, Lowell, MA). Samples were covered
with 200 µL of ultra pure water and sterilized through exposure to UV radiation for 30
minutes. VICs were seeded onto substrates at 25,000 cells/cm2 in assay media with 3%
(v/v) FBS. After 7 days of culture, cells were fixed with formalin for 30 min and washed
twice with phosphate buffered saline (PBS). Cells were then permeabilized with 0.01%
(v/v) Tween20 for 15 min. Permeabilized cells were washed twice with PBS followed by
a block with a 3 wt% bovine albumin serum(BSA)/PBS for 1 hour. Samples were
incubated with primary antibodies for phenotypic markers or extra cellular matrix
proteins for in a 3wt% BSA solution. Antibodies used for phenotypic expression were
mouse α-smooth muscle actin (αSMA, ab7817, 1:100, AbCam, Cambridge, MA) and
rabbit core binding factor-1 (CBFa-1, CBFA11-A, 1:100, Alpha Diagnostic, San
Antonio, TX) identified aVIC or obVIC. Antibodies used to identify ECM associated
proteins included collagen-I (1:100, ab90395, AbCAM) and elastin (1:100, ab21610,
AbCAM). After a 90 minute incubation with primary antibody solution and cells were
washed twice with PBS. One set of secondary antibodies was used for both the
phenotypic markers and ECM components, goat anti-mouse AlexaFluor 488 (1:75,
A11001, ex 495 / em 519, Invitrogen) and donkey anti-rabbit AlexaFluor 647 (1:75,
A31573, ex 650 / em 665, Invitrogen) in a 3wt% BSA solution. Following incubation for
90 minutes in the secondary antibody solution, cells were counter stained with DAPI in
PBS (1:1000, Invitrogen) for 5 minutes. Samples where then removed from the 96 well
plate and mounted on coverglass using mounting media (Fluoromount, F4680-25ML,
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Sigma-Aldrich, St. Louis, MO) and sealed with clear nail polish. Staining controls to
insure non-specific binding of the secondary antibodies was performed on substrates with
and without VICs.
Samples were imaged on a Zeiss Axioskop 2 MOT microscope (Standort
Göttingen - Vertrieb Deutschland) with Plan-Apochromat 63x oil 1.4 NA objective
(Zeiss) and a Nuance Multispectral Imaging System FX Camera (Cambridge Research
and Instrumentation, CRI, Hopkinton, MA). Images were captured and analyzed using
Nuance Software (3.0.1, CRI). Quantification of the fluorescence in the images required
comparison to control standards of cells incubated with primary, secondary antibody, and
DAPI separately to remove background, auto-fluorescence of cells fixed to surfaces, and
assign a reference spectrum to each stain. Phenotypic staining resulted in αSMA stained
green (λ =519 nm), CBFa-1 stained in far red (λ =655 nm), and nucleus stained blue (λ =
461 nm). ECM production staining resulted in collagen-I stained green (λ =519 nm),
elastin stained in far red (λ =655 nm), and nucleus stained blue (λ = 461 nm).

2.8. Sulfanted Glycosaminoglycans (sGAG) Production
Four samples of each substrate formulation were loaded into flat bottom non-tissue
culture polystyrene 96 well plates (3370, Corning, Lowell, MA). Samples were covered
with 200 µL of ultra pure water and sterilized through exposure to UV radiation for 30
minutes. VICs were seeded onto substrates at 25,000 cells/cm2 in assay media with 3%
(v/v) FBS. Briefly, at 2 day and 7 day media was removed and retained for testing. Cells
were washed with DPBS and digested with papain extraction reagent as specified by
manufacturer for 3 hours at 65° C. Digested extract was centrifuged at 10,000g for 10
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minutes and the supernatant was retained for assay. Quantification of sGAG was
determined by testing the media and the digested extract separately using the Blyscan
sGAG Kit (B1000, Biocolor, Carrickfergus, UK) at days 2 and 7. Assay was performed
according to manufacturer‘s protocol. Dye reagent was added to test solution, and
incubated for 30 minutes on a mechanical shaker. The sGAG-dye precipitate was
concentrated by centrifugation. The supernatant was then removed and the sGAG-dye
precipitate was resuspended using the dissociation reagent and absorbance was measured
at 656 nm using a plate reader (M2, Molecular Devices, Sunnyvale, CA). Total sGAG is
calculated by the sum of cell culture media and extract.

2.9. Statistical Analysis
Nanoindentation, variable serum conditions, proliferation, phenotypic expression,
sGAG production, and ECM protein secretion results were analyzed using the TukeyKramer one-way nonparametric analysis of variance (ANOVA) with values of p < 0.05
considered statistically significant. All analysis were done with InStat 3 (GraphPad
Software, La Jolla, CA). All data are presented as mean ± standard deviation.

3. Results
3.1. Nanoindentation
The mechanical properties of the substrate surfaces were characterized with
nanoindentation. Table 3-2 displays the maximum load values obtained to reach a 4000
nm depth in each sample.
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Table 3-2. Maximum load applied to reach a depth of 4000 nm

Max Load
(mN)
0.45 ± 0.02
3.17 ± 0.16
6.02 ± 1.57
24.62 ± 3.37

3% DEGDMA
19% DEGDMA
25% DEGDMA
33% DEGDMA

Figure 3-1 shows the reduced modulus (Er) for each material formulation.
Evaluation by nanoindentation display a three order of magnitude increase in material
properties (Er = 6.5 – 1,500 MPa) between the 3 and 33 wt% DEGDMA formulations.
Differences between formulations were found to be significant with p < 0.01. The
standard deviation of the Er of the 3% DEGDMA sample was found to be within in the
signal noise and displayed as zero.
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Figure 3-1. Reduced Modulus (Er) nOM / DEGDMA formulations determined by nanoindentation. Tissue culture
polystyrene (TCPS) was also measure using the same nanoindenter setup (Er = 30.6 ± 10.9 GPa). * p<0.01
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3.2. Variable Serum Conditions
In order to minimize effects of changes in cell number over time in all further
experiments, studies to determine the minimum serum concentration necessary to
maintain viability and morphology were conducted. Additionally, when many cell types
density reaches higher levels intercellular signaling slows growth but, VICs at higher
confluency begin to exhibit obVIC characteristics.11, 16, 23, 42 Cell number and spreading
were assessed for up to nine days in media containing 0, 1, 3, 5, or 10% FBS. As shown
in Figure 3-2, the number of cells attached was independent of serum concentration, with
a reduction in cell attachment observed only with 0% FBS media. Throughout the rest of
the study a statistically significant increase in the cell number was observed for the
positive control (10% FBS) at each time point (p<0.05). In media with 1, 3, and 5%
FBS, no increase in the cell number was detected, while a decrease in cell number
occurred under 0% FBS conditions.
Figure 3-3 shows brightfield microscopy of VICs which revealed the changes in the
morphology of the cells over the course of the experiment. Cell number increase in 10%
FBS to a confluent culture at 7 days with an aligned and spindle shaped morphology
(Figure 3-3 a2-a4). The 3% FBS appears to allow cells to attach and spread on the surface
without a significant change in morphology over the course of the study (Figure 3-3 d1 –
d4). Cells in 1% FBS attach to the surface, but as compared to cells in 3% FBS media did
not spread to the same extent (Figure 3-3 c1 – c4). A limited number of cells to attached
with 0% FBS media and all cells detached by day 3 (Figure 3-3 d1 – d2).
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Figure 3-2. Cell number as a function of FBS concentration over a 9 day culture period with no media changes. No
significant differences were found between the different time points for cells cultured under reduced serum
conditions (5,3,1 % FBS), n=4
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Figure 3-3. Brightfield imaging of VICs cultured in varying levels of FBS over a period of 9 days without media
changes. VICs cultured in 10% FBS grew to a confluent culture within the nine day observation period with
morphology representing smooth muscle cells aligned and spindle shaped (a1 – a4). VICs grown in 5% FBS attach
and spread then begin to retract processes by the ninth day (b1 – b4). The VICs in 3% FBS attach and spread on the
surfaces without significant changes in morphology (c1 – c4). VICs in 1% FBS attach to the surface but do not show
the same level of spreading as compared to VICs in higher concentrations of FBS (d1 – d4). A limited number of VICs
rd
attach and extend processes, by the 3 day in culture no apparent cells are attached to the surface cultured in 0%
FBS (e1 – e2).

3.3. Cell Proliferation on Substrates
Cell number was determined under normal culture conditions (10% FBS) 1, 2, 4 and
7 days after seeding on varying stiffness substrates. The number of VICs was measured
with three different methods (flow cytometry, fluorescence microscopy with computer
analysis and by manual counting). Results are presented in Figure 3-4. It was determined
by all three methods that the stiffness of the underlying substrate had no statistically
significant impact on the attachment or the cell number at each timepoint. This data
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suggests that the stiffness of the substrate does not influence the rate of the proliferation
of VICs when incubated under normal culture conditions.
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Figure 3-4. Number of viable cells stained with CyQuant Direct Cell Proliferation assay measured with 3 different
methods A) flow cytometry, and fluorescence microscopy followed by B) automated and C) manual analysis. n=4
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3.4. Phenotypic Expression
The phenotype marker αSMA was selected as the marker for the desired aVIC
phenotype and the transcription factor CBFa-1 was used for the identification of the
obVIC. Results presented in Figure 3-5 show no statistical significant difference in
αSMA expression levels between formulations and the TCPS control, indicating that
stiffness alone does not affect expression of αSMA. Representative images of phenotypic
ICC staining can be seen in Figure 3-5. VICs cultured on the three stiffest materials
(Figure 3-6 B - D) showed distinctive αSMA stress fiber organization. The VICs on the
softest material had little stress fiber organization (Figure 3-6 A).
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Figure 3-5. Alpha smooth muscle actin expression (αSMA) per cell by VICs cultured on the various rigidity nOM /
DEGDMA substrates normalized by cell number. There is no statistical difference in αSMA expression between the
formulation or the tissue culture polystyrene control (TCPS). n=3

The staining of CBFa-1 was found at barely detectable levels above the background
sporadically on the different substrates as shown in Appendix Figure 3-12. There were
not significant levels to confidently quantify the expression levels with the spectral
imaging techniques used.
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Figure 3-6. Immunocytochemistry stain VIC phenotypic staining after 7 days in culture in reduced serum conditions.
A) 6 MPa, B) 186 MPa, C) 500 MPa, D) 1,500 MPa. Green = α-smooth muscle actin, Red = Core Binding Factor 1, Blue
= DAPI, Scale Bar = 10 µm
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3.5. ECM Production: Sulfated Glycosaminoglycans
The sGAG content after 2 and 7 days of culture in reduced serum conditions (3%
FBS) are shown in Figure 3-7. A significant increase in the amount of sGAG produced
was observed on all formulations between day 2 (~1.5 µg/well) and day 7 (~12 µg/well).
No significant difference was found in sGAG production on the different formulations at
either time point (p>0.05). Reduced serum culture conditions ensured that there was not
an increase in the number of VICs over the experiment, as determined in the variable
serum condition experiments presented earlier, Figure 3-2.
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Figure 3-7. Total sulfated glycosaminoglycans (sGAG) content of valvular interstitial cells (VICs) cultured on the
varying stiffness substrates. No significant difference was observed between the different substrates or the tissue
culture polystyrene control at day 2 or day 7. n=4
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3.6. ECM Production: Collagen-I and Elastin Expression
The amount of collagen-I and elastin was quantified using spectral imaging after 7
days of culture. There was no difference in the normalized expression of collagen-I
between any of the nOM / DEGDMA formulations and TCPS control (Figure 3-8).
However, the cells on the 6 MPa substrate did show a significant (p<0.05) increase in
elastin production over the 520 and 1,500 MPa substrates (Figure 3-9). Figure 3-10

Normalized Collagen-I Expression
(Counts / # of Cells)

shows representative images of collagen-I and elastin staining counter stained with DAPI.
400000
350000
300000
250000
200000
150000
100000
50000
0
6 MPa

190 MPa

520 MPa

1500 MPa

TCPS
(Er = 30 Gpa)

nOM/DEGDMA Substrate Stiffness
Figure 3-8. Collagen-I expression (Col-I) of valvular interstitial cells (VICs) cultured on substrates of varying rigidity.
Change in the rigidity of the VIC culture substrate has no statistical difference of the expression of Col-I after
culture for 7 days in reduced serum conditions. n=3, p > 0.05
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Figure 3-9. Elastin expression determined by ICC staining and spectral imaging quantification. Change in the rigidity
of the VIC culture substrate is inversely proportional to the expression of elastin after culture for 7 days in reduced
serum conditions. A significant upregulation of elastin expression was observed of the 6MPa substrates over the
520 and 1,500 MPA substrates. Although tissue culture treated polystyrene (Er = 30.62 ± 10.87 GPa) is stiffer than
the 1500 MPa substrates, the difference in the surface contributes to the change in elastin expression. n=3, *
p<0.05
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Figure 3-10. Immunocytochemistry stain VIC ECM Production staining 7 days culture in reduced serum conditions.
A) 6 MPa, B) 190 MPa, C) 520 MPa, D) 1500 MPa. Red = Elastin (upper left), Green = Collagen I (lower left), Blue =
DAPI (upper right), Merged (lower right), Scale Bar = 20 µm
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4. Discussion
The work presented here shows the isolated effect of substrate stiffness on the
phenotypic expression on VICs as examined by rate of proliferation and expression of
phenotypic markers αSMA and CBFa-1. In addition, the production of sGAG, collagen-I,
and elastin was also assessed. These studies utilized substrates, nOM / DEGDMA, which
allowed for varying bulk modulus from 20 to 5,000 kPa with similar surface features.
Nanoindentation is a technique that samples the mechanical properties of small
volumes of a material within microns of the surface. This technique is well suited for the
study of materials that will directly interact with cells adhered to the surface. When cells
are adhered to a surface, the cytoskeleton of the cell produces shear stress on the material.
These cell induced stresses can propagate into the material 50 µm from the surface.43
Therefore, any of the material that is greater than 50 µm from the surface will not have an
effect on the cells. Nanoindentation allows for the sampling of the material‘s properties
that is relevant to cells adhered surface.
The observed trend of increasing stiffness with an increase in DEGDMA content is
the same as previously observed in compression testing of bulk materials. Bulk
compression testing showed an increase from 25 to 4,700 kPa with an increase of 3 to 33
wt% DEGDMA crosslinker. Nanoindentation of the materials found an increase from 6
to 1,500 MPa with increase of 3 to 33 wt% DEGDMA. The two order of magnitude
difference of the moduli measurements between the bulk material testing and
nanoindentation is attributed to the difference of sample volume analyzed and the type of
modulus examined. In polymeric materials, small volumes versus bulk material may have
very different properties due to cyclization and, void volumes and differences in
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sampling methods.33, 36, 44 Bulk compressive modulus also measures the combined
properties of plastic and elastic modulus, where nanoindentation only measures the
elastic (reduced) modulus. In the bulk material, a larger increase is seen between the 3, 19
and 25 wt% materials (160% increase) than with nanoindentation (86% increase). The
sharp increase in the material modulus that is observed in bulk material testing between
the 19 and 25 wt% DEGDMA materials is not observed when the material is tested using
nanoindentation. In the bulk material, this transition is contributed to the change of how
DEGDMA contributes to the overall mechanics. In the lower DEGDMA content
materials, DEGDMA crosslinks polymer chains of primarily nOM. The higher
DEGDMA content substrate, DEGDMA becomes a significant part of the polymer
backbone. The lack of this sharp transition observed with nanoindentation between the 19
and 25 wt% DEGDMA materials suggest that in small volumes and only the elastic
modulus, the role DEGDMA plays in the polymer backbone is not as profound as in the
bulk. Nanoindentation demonstrated that the modulus of a material at a cellular level is
not the same as the bulk measurements.
In the native valve, VICs occupy the environments that are primarily composed of
elastin and collagen.15, 45 Direct measurement of individual fibers of elastin and collagen
by atomic force microscopy has yielded measured elastic moduli of 1 and 200 – 7500
MPa, respectively. The nanoindentation results of nOM / DEGDMA networks shows that
these polymer substrates are appropriate for modeling the majority of the native ECM of
the VICs on the cellular level.
To be able to isolate the impacts of substrate rigidity on various cell functions it is
important to be able to control cell density during a study. If population‘s numbers
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change, results would be difficult to interpret because of alterations in cell-cell signaling
over the course of the experiment.46 Experimentation started to determine the minimum
serum concentration necessary support VIC viability but limit proliferation. The cell
number and morphology were evaluated over nine days in media with varying
concentrations of serum. It has been previously demonstrated that cells under varying
serum conditions (1 - 10% FBS) have limited changes in the phenotypic expression based
on expression of activated marker, αSMA, after several culture passages.38
The quantification of the VICs under normal, reduced and depleted serum conditions
allowed for the determination of the minimum serum conditions to arrest cell growth over
an extended cultured time. Representative bright field microscopy images show that cells
cultured in 3% FBS (Figure 3-3 c1 – c4) allow for cell spreading greater than seen with
the 1% FBS (Figure 3-3 d1 – d4). Cells under 3% FBS maintained the spread
morphology throughout the extent of the study with no statistical change in cell number.
These results suggest that 3% FBS is the minimum serum concentration to isolate the
impact of an underlying substrate without convolution by changes in cell density.
The results of VIC proliferation on the substrates of varying rigidity contrasts with
that of Yip et al. Yip studied VICs cultured on collagen gels of varying thickness (10 µm
and 2.5 mm) mounted on TCPS, which where modeled to have moduli of 2,000 and
6,000 N/m, respectively.23 Yip et al. found that the VICs cultured on the compliant
collagen gels had a significantly higher rate of proliferation than that of cells on the
stiffer gels. The collagen gels were characterized as having similar collagen fiber
diameters and limited changes in the individual sample stiffness over course of the
experiment. However, significant degradation of some of the gels was observed. The
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combination of the different thickness of collagen gels and the degradation over the
culture period may have presented the cells with unstable surface chemistry. The thin gels
used (10 µm), may have allowed the underlying TCPS to affect cell adhesion. In this
study, therefore, it is difficult to assume that the variation of gel stiffness is the only
property influencing cell function. The newly introduced substrates composed of nOM /
DEGDMA have been developed to overcome the problems of variation in substrate
surface properties over a range of moduli. The results of shown in Figure 3-4 show that
even with a three order magnitude change in substrate rigidity no significant difference is
seen in cell numbers between substrate formulations. Combining the results from Yip et
al. and VICs cultured on nOM / DEGDMA substrates suggests that it may be the
difference in substrate chemistries inducing the changes in cell numbers between
substrates and not the stiffness of the substrate.
A simple viability assay was used to fluorescently stain viable cells to determine the
number of cells on each substrate by three different methods (flow cytometry, automated
image analysis and manual image analysis). Each method has its advantages and
disadvantages. Manual fluorescent image analysis has long been used to quantify cell
number as it is inexpensive and easily implemented. The use of image analysis software
is a higher throughput method, capable of analyzing entire images quickly and accurately.
Image analysis software relies on the acquisition of representative images of samples to
be able to quantify cell numbers and the implication of correct algorithms. The software
analysis of images relies on a combination of size, intensity ratio
(foreground/background) and sharpness of objects edge to determine number of cells in
an image. The software applies the same algorithm to each image consistently analyzing
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the images. The manual method of verification relies on the same basic principles of
object identification as the software. However, instead of a mathematical determination
of object identification it is completely based on operator judgment. Flow cytometry is a
high throughput/high accuracy method that is capable of analyzing entire samples.
However, flow cytometry only works on suspensions of cells and not cells adhered to a
surface. Requiring that cells be lifted from surfaces before analysis by either enzymatic
digestion or mechanical contact. Results from the three different methods were compared
to determine consistency in the analysis methods.
All of three methods used to analyze the number of cells on the substrates resulted in
observation of the same trends throughout the study. The standard deviation for all
methods increases with culture time, but the increase is more dramatic with the methods
associated with image analysis (Figure 3-4, (B) computer or (C) manual). The manual
analysis of the microscopy images has the greatest standard deviation. The large standard
deviation is associated with the clustering of cells as cell density increased. This
comparison shows that computer image analysis is the preferred method of analysis as it
is capable of analyzing entire populations and is accurate due to automation. Automated
image analysis can also provide additional information regarding varying cell densities
across a single substrate.
Spectral imaging was selected as the method to analyze the phenotypic markers
(αSMA, CBFa-1) and ECM production (collagen-I, elastin) as it directly measures the
target.47, 48 Spectral imaging lowers the detection limit of target over that of an RGB
image, as the spectrums of each stain are used as standards to separate the contribution of
stain versus background. Separation of each spectrum allows for the detection and
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quantification of multiple stains on the same sample. However, the technique requires a
lower limit of target that is dependent on sample preparation and stain used making it
highly dependent on the accuracy of the control spectrums.
The VICs have characteristics of fibroblasts, smooth muscle cells, myofibroblasts and
osteoblasts.19, 38, 49 Native VICs in an adult healthy valve are predominantly fibroblast
like, known as the quiescent phenotype (qVIC)16. The transition to aVIC phenotype is
marked by the expression of α-Smooth Muscle Actin (αSMA) and stress fiber
formation.16, 17 The aVIC is the desired phenotype for tissue engineering applications as it
is associated with higher rates of ECM synthesis and proliferation in vivo.14 The
expression level of αSMA was not impacted by the stiffness of the substrate (Figure 3-5),
indicating that VICs cultured on all of the substrates showed that all of the VICs were of
the aVIC or obVIC phenotype. Our αSMA expression results compliment the work by
Benton et al. which found that expression of αSMA on fibronectin coated PEG hydrogels
(modulus of 100 kPa) compared with TCPS did not change. It was only when Benton et
al. used a different protein, fibrin, was an increase in αSMA expression observed on
TCPS over the PEG hydrogels.14
Although the αSMA expression was consistent across the surfaces structural changes
within the VICs were observed. As can be seen in Figure 3-6, stress fibers of αSMA were
diffuse on 6 MPa substrates and more distinct in all other treatment groups. The
difference in stress fiber organization is most likely due to the substrates‘ ability to resist
the shear stress the cells create.38, 50 As the focal adhesions and stress fibers are
assembled, there is a continuous cycle of tension and alignment producing varying levels
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of stress fiber organization.19 The stiffer nOM / DEGDMA substrates resist the cell
induced shear stress allowing for greater stress fiber organization.
It has been shown that environmental conditions can cause the aVIC to differentiate
into the obVIC while still expressing αSMA.14 The osteoblastic phenotype has been
associated with the stiffing of the AV and that a stiffer culture substrate would
upregulates the obVIC.22 Expression of CBFa-1 was detectable but not quantifiable in the
positive control (Appendix Figure 3-12) which dictates the calculation of expression
levels. However, expression was not detectable at significant levels on any of the
substrates to allow for quantification of expression using the spectral imaging technique.
The low amounts of CBFa-1 observed suggest that additional factors in either the culture
media or bound to substrate are required to promote the obVIC phenotype and that
simply culturing VICs on stiff substrates does not induce the obVIC. This conclusion is
supported by the work of Benton et al. which found that only after the addition of fibrin
to either TCPS or PEG hydrogels was there a considerable increase in the levels of
CBFa-1 expressed after 6 days of culture. The previous work combined with the results
presented here show that substrate rigidity is not the dominating effect on cell phenotype
but still may play a role as a moderator of cell sensitivity to soluble factors.
Glycosaminoglycans are linear chains of disaccharides repeat units that serve
structural as well as cellular signaling compounds.51 It was found that out of the two
primary classes of GAGs present in the AV (sulfated and hyaluron) VICs incorpurate,
90% sGAG and 10% hyaluronan into the ECM.41 The dimethylmethylene blue (DMMB)
assay was selected to easily and quickly assess the total amount of sGAG produced by
VICs into the matrix.41 Previously, Gupta et al. showed that VICs mechanical
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environment affects the amount as well as type of GAGs produced. Gupta et al. found
that VICs cultured in collagen gels constrained to produce stain as the cells contracted the
gel increased the incorporation of total GAGs into the surrounding matrix over that of
VICs cultured in unconstrained gels. No direct relationship between the stiffness of the
substrate and the production of sGAG was found in studies using nOM / DEGDMA
substrates. The differences observed between this study and the work by Gupta et al. can
be attributed to several factors. The use of the collagen gel for a scaffold offers the
advantage of easily fabricating an environment composed of natural materials, but may
introduce additional variables that could in fact be affecting the behavior of the VICs. To
introduce the variable mechanical environments Gupta et al. strained the collagen gel,
which may change the cell environment as the collagen fibers are strained the fibers will
align and change the microenvironment of the cell.52.
For the goal of tissue engineering, it is important to induce VICs to produce the
primary structural proteins of the native AV ECM, collagen and elastin. Collagen-I
makes up the bulk of the collagen present in the valve and is critical to allow the valve to
resist the tension placed on it during normal function.24 Previous ex vivo studies has
shown that VICs in native ECM will upregulate the production of collagen when place
under strain, which has led to the investigation of the role of substrate rigidity in ECM
production.53 This phenomenon was investigated with an in vitro model where VICs were
cultured on flexible substrates coated with collagen-I. When the substrates were placed
under increasing levels of strain, the production of collagen increased as well.24 Placing a
material under stress will increase the rigidity of the material, but it also affects the
surface properties of a material, including alignment of collagen fibers. In these studies
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where the cell culture substrate is strained to produce changes in material mechanics, it is
difficult to discern if it is the increase in material rigidity or other changes in the material
are inducing certain cell functions. Additionally, the rate at which a material is stained
can influence the response of VICs, which raises the question of if the synthesis of
collagen was due to the resulting stiffness of the material or the rate at which the strain
was applied.54, 55 Comparison of the results of previous studies and the results presented
here suggests that it was the changes in the surface that were induced by the stretching
that caused the change in the level of collagen expression. This hypothesis is further
supported by the work of Shah et al. and Benton et al. with degradable PEG based
hydrogels and TCPS, where levels of collagen expression were only impacted by the
addition of exogenous soluble signals.10, 40
Elastin is necessary in the valve to maintain the collagen structures and allows for the
recoil of the valve during normal function. However, it has proved difficult to induce the
production of elastin in vitro and in vivo.1, 6 A major discovery by Masters et al. and Shah
et al. found that culture media supplemented additional hyaluronic acid (HA, 3 µg/mL)
upregulated VIC elastin production.6, 10 Shah et al. used VICs encapsulated in degradable
hydrogels of HA / PEG. As the gels degraded releasing HA, the expression of elastin
increased.10 Although mechanical testing was not performed, mass loss and gel
dissolution occurred of the hydrogels even with the production of ECM components by
the VICs. This suggests that mechanical rigidity of the three dimensional structure
decreased over the course of the study.56 Combining this with our elastin production
results presented in Figure 3-9 suggests that the significant increase in the amount of
elastin produced seen by Shah et al. was a compound effect between the HA stimulation

90

and the decreased rigidity of the gel due to degradation. It is possible that VICs increase
the amount of elastin produced on softer substrates because the modulus was similar to
that of elastin fibers which are primary found in the ventricularis.
While results are encouraging, there are some limitations to this study. Quantification
of the protein expression by ICC spectral imaging allowed for the direct analysis of
expressed proteins associated with phenotypic expression and ECM secretion. However,
expression of proteins must be at a high enough level to be able to confidently distinguish
the fluorescence associated with desired protein over that of the background. Use of
quantifiable real time-polymerase chain reaction (RT-PCR), could be used to supplement
the spectral imaging results, as it is capable of detecting small changes in levels of
mRNA. It should be noted however, that mRNA expression does not directly correlate to
protein expression, due to the time for cells to produce the proteins as well as regulation
pathways associated with protein expression. The results presented here could be
supplemented with RT-PCR to obtain a more sensitive analysis of expression. In
addition, this study was limited to only analysis of the sGAG produced by the VICs, this
does not examine hyaluronic acid expression that could be affected by the rigidity of the
substrate. Fluorophore-assisted carbohydrate electrophoresis (FACE) could be used to
analyze all the different classes of GAGs to develop a complete picture of GAG
production. Only a single type of collagen production was evaluated, this limits the study
as it does not examine the regulation effects of the changes in type of collagen produced.
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5. Conclusion
Cell culture substrates fabricated from nOM / DEGDMA were utilized with a three
order magnitude increase in the reduced modulus (Er) to determine the isolated impact of
substrate rigidity on the proliferation, phenotype and ECM production of VICs.
Nanoindentation was employed to determine the material stiffness at the cell-substrate
interface, finding that the nOM / DEGDMA substrates utilized of varied from 6 to 1,500
MPa, covering the majority of micro mechanical environment experienced by VICs in
native tissue.57 To properly test VICs for proliferation, phenotype and ECM production it
was desired to find a minimal media serum level that allowed for VIC viability and
spreading while limiting proliferation. It was found that media supplemented with 3%
(v/v) serum allowed for efficient cell adhesion, limited proliferation, and did not
significantly affect the morphology of the cells. It was found by three different methods
that the rigidity of the culture substrate did not have a significant difference in the
proliferation of VICs. Through immunocytochemistry staining of phenotype marker
αSMA, no difference was found between the levels of expression after 7 days of culture.
The marker for the diseased osteoblastic phenotype was not detectable. Phenotypic
evaluation concluded that all surfaces produced aVICs, while obVICs were not a
significant portion of the VIC populations. Production of the major ECM components
sGAG and collagen-I had no statistical difference between the different substrate
rigidities. However, softer substrates (Er = 6 MPa) had significantly higher levels of
elastin produced over the stiffer substrates (Er = 500, 1500 MPa). The results of these
studies offer the ability to separate out the independent impact of substrate rigidity on
VIC functions. It was found that the substrate rigidity only affected the production of
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elastin with no detectable difference in the proliferation, phenotype, or production of
other ECM components.
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6. Appendix

Figure 3-11. Flow cytometry analysis of VICs untreated (A) and incubated with 70% v/v Methanol/water (B) stained
with CyQuant Direct Cell Proliferation Assay. The 2 part assay stains DNA fluorescent green, cells with
compromised membranes the fluorescent signal is suppressed as seen in the comparison of the FL1-A histograms
between (A) and (B).
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Figure 3-12. Emission spectra of αSMA positive and a single CBFa-1 positive VIC verifying the ICC staining method
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1. Conclusions
Aortic valve disease is of major clinical importance in the United States, affecting
approximately 100,000 people each year.1, 2 The lack of sustainable treatments has led
researchers to develop a living tissue substitute for diseased tissue. The stiffening of the
AV in disease states has encouraged researchers to develop in vitro cell culture platforms,
which are a model capable of revealing the phenotypic patterns of cells during health and
disease of the AV. While invaluable information has been gathered on the response of
VICs to the stiffness of the supporting substratum, many have been obscured by a variety
of complicating substrate factors. Most notably, the change in surface features over a
physiologically relevant range has complicated results.
Tissue engineering of the aortic heart valve (AV) has the potential to be the next
generation of therapies for replacing or repairing diseased and damaged valves. However,
after initial success of tissue scaffolds in animal models, it became clear that a greater
understanding of the cellular biology of the primary cell population of the AV, valvular
interstitial cells (VICs), was needed.3 Inducing VICs to produce structural extra cellular
matrix (ECM) components of AVs is a multifaceted problem. The plastic phenotype of
the VICs has to be modulated along with induction of ECM production.4 A proper
balance between the physical properties of the substrate and soluble signaling factors is
extremely important to direct VIC functions for AV tissue engineering applications.3, 5
Maintaining this balance between the material and soluble factors is convoluted
by limitations imposed by current cell culture platforms. For example, isolating effects of
substrates rigidity on VIC biology from those imparted by differences in substrate
chemical composition and topographical features has been difficult.6, 7 We sought to
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develop a new cell culture platform that is capable of exhibiting a wide range of
physiologically relevant moduli without significant variation in the surface. In this work,
we developed a culture platform using n-octyl methacrylate (nOM) / diethylene glycol
dimethacrylate (DEGDMA) that would allow for the systematic evaluation of substrate
modulus on VIC biologic functions while maintaining a consistent surface.
The material platform composed of varying amounts of nOM and DEGDMA, which
produced a substrate with a range covering three orders of magnitude. Differences in
modulus in the bulk polymer (25 – 5,000 kPa) as well as on the surface (6 – 1,500 MPa)
were seen. Analysis of the surface indicated that the wettability (contact angle of 90°),
topography (Rrms of 17 ± 6 nm), chemical composition (~70% aliphatic carbon) and total
amount of protein adsorbed (~18 µg BSA/cm2) varied little over this entire range of
moduli. This platform will potentially enable studies of cellular biology associated with
initiation and progression of diseases outside the AV, that are characterized by a
stiffening of the tissue, including liver fibrosis8 and many cancers.9
The successful fabrication of the nOM / DEGDMA substrates allowed for the first
evaluation of the impact of rigidity on VICs without complications from changes in the
topography and chemical composition of the surface. For example, protein markers for
the activation of VICs (αSMA) showed no significant variation (p>0.05). The marker of
disease-state, core binding factor-1 (CBFa-1), was barely detectable on any of the
materials, indicating that rigidity alone was not enough to produce a diseased phenotype.
No significant difference (p>0.05) was found in the production of sulfated
glycosaminoglycans and collagen-I, on any of the materials. Softer materials, however,
yielded a significantly greater expression of elastin (p<0.05).
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We have successfully demonstrated that an easily fabricated cell culture platform of
nOM / DEGDMA could be used for cell culture studies. The substrates have a large range
of physiologically relevant moduli in the bulk polymer as well as on the surface. The
materials maintained similar chemical and topographical features across the entire range.
This enabled us to perform the first analysis of the phenotypic expression of VICs with
isolated impact of substrate rigidity. The results obtained will be used to further the
understanding of the regulations of phenotypic transitions of the VICs as well as design
three-dimensional scaffolds for the engineering of AV tissue.
The successful development of the base platform allows for the advancement of
surface modification to probe the events at the material/VIC interface. This understanding
will in turn provide the foundation of engineering VIC encapsulated constructs that
mimic healthy AV tissue. Below we present our vision of those parameters that need to
be defined in addition to modulus to form an effective material/VIC interface. They
include surface topography, relative hydrophobicity, and functionalization. Optimizing
these features along with modulus will enable more effective engineered tissues.

2. Future Directions
2.1. Nanotopography – Preliminary Studies to Support Future Work
The objective of this section is to identify material platforms with defined substrate
stiffness and topography that direct tissue formation from the VICs. Many methods have
been used to generate micron to nanometer scale topography for tissue engineering
applications, including but not limited to shadow masks, photolithography, electron
beam, and focused ion beam lithography directly on a cell culture substrates.10-12 These
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methods can be used to fabricate a stamp to use in lithography to increase the number of
substrates that can be fabricated. In this method, the surface features of a stamp are
transferred to a substrate by mechanical contact with an uncured monomer solution
followed by photo or thermal induced crosslinking. Ultraviolet nanoimprint lithography
(UV-NIL) was chosen as it is both a high throughput and high fidelity method, which
avoids the use of additional heat for curing that causes problems of stamp destruction due
to thermal expansion. 13 The UV-NIL process allows for the generation of materials with
feature sizes down to ~10 nm. The small feature size is possible because the use of low
viscosity monomer solutions do not require heat for mold filling. Without the additional
heat temperature gradients and differences in thermal expansion between the stamp /
substrate are avoided.14
By combining the rigidity-controlled network of poly(nOM-co-DEGDMA) with
topographical features produced using UV-NIL, a new multi-functional substrate can be
fabricated. The new platform will be used to simultaneously determine the impact of
variation of both ordered surface topography and substrate compliance on the cellular
functions of VICs. The fabrication of substrates entails a number of steps. Working
stamps were fabricated from the master mold by solvent casting of a thin fluoropolymer
film (Figure 4-1A, 1 and 2), Dupont Teflon AF 2400 (2,2-bistrifluoromethyl-4,5difluoro-1,3,-dioxole (PDD) and tetrafluoroethylene (TFE)) in perfluorinated solvent
(FC40, 3M) at 165°C and -22 inHg for 6 hours.13, 15 Polydimethlysiloxane (Sylgard 184,
Dow) was also evaluated as a potential working mold material, but was discarded when
swelling of the mold was observed upon application of the nOM / DEGDMA monomer
solution. The fluoropolymer mold overcomes many of the problems associated with using
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a rigid mold for UV-NIL, including mass transport/variable pattern filling and the need
for surface treatment to allow mold release.14, 16 The fluoropolymer mold helps to reduce
mass transport/variable pattern filling, as it is a flexible film that is capable of conforming
to any long-range undulations. The fluoropolymer mold is easily released from the
resulting cured material because of its low surface energy of 15.6 dyne/cm.15 The low
surface energy has the added benefit for biological applications, as it will help limit
possible surface contamination of the final substrate with the stamp materials. A photocurable solution of monomers, nOM and DEGDMA, is placed over the fluoropolymer
working mold (Figure 4-1A, 3 and 4). The rigidity of the substrate is independently
controlled by the ratio of the photo curable monomers. Figure 4- 4B, shows the
fabrication method utilized to generate free standing nOM / DEGDMA substrates with
nanotopography on the surface. Using this method, it is possible to generate cell culture
substrates with tunable rigidity and surface topography as shown in Figure 4-2.

Figure 4-1. Schematic illustration of ultra violet nanoimprint process (UV-NIL). A thin film on a silica wafer is
patterned using interferomatric lithography(A1), a fluoropolymer working stamp is solvent casted on to the
patterened silica wafer (A2), then a acrylate monomer solution is poured over the working stamp and cured with
UV (A3), the acrylate is easily removed from the working mold because of the low surface energy of the working
stamp. Placing the working fluoropolymer stamp in the quartz mold can be used to generate freestanding submicro patterned substrates (B)
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The results in Figure 4-2 show that the majority of the pattern from the master stamp
(A) is transferred to the working fluoropolymer stamp (B) and finally to a UV cured
nOM/DEGDMA substrate. The variable filling of the master stamp with the
fluoropolymer solution as well as incomplete filling of the fluoropolymer stamp with
nOM/DEGDMA monomer solutions results in the hill and valley effect seen. These
results demonstrate the feasibility of creating submicron topography features on a
freestanding cell culture substrate. Optimization of the solvent casting of the
fluoropolymer by determining the rate at which the solvent is evaporated. The rate is
easily controlled by varying temperature and pressure. These variations in the process
will help to eliminate mass transfer problems that result in undulations in the final
substrate.

Figure 4-2. Scanning Electron Microscopy Images of the (A) master stamp, (B) working AF stamp, (C) nOM/DEGDMA
patterned substrates. Optimization of the process will help to eliminate mass transfer problems that result in
undulations in the final substrate

The nOM / DEGDMA platform has proved to be capable of adding sub-micron
ordered surface topography. Optimization of the imprinting process could produce
substrates with ordered topography and moduli control. The combined impact of surface
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rigidity and topography moves the field closer to mimicking the native in vivo
environment.

2.2. Chemical Surface Modification
A significant dependence of the chemical surface that is presented to the VICs on the
phenotypic and ECM secretion has been observed.17, 18 Non-specific protein adsorption
from serum onto synthetic substrates is the simplest method for promoting cell adhesion.
The adsorption of serum components is dependent on the substrates wettability and
topography.19, 20 Non-specific protein adsorption of the nOM/DEGDMA substrates can
be modulated using chemical treatments. For example, the contact angle can be decreased
using an oxygen plasma to add hydroxyl groups.21 The surface could also be made more
positive by treatment with a weak aqueous acid.22 This would result in a decrease in the
contact angle with the protonation of the surface.
Specific control of the VICs could be achieved by the adsorption of specific native
ECM components such as fibronectin, collagen, heparin and hyaluron. All of these ECM
components have shown to influence both phenotypic markers and ECM secretion of
VICs.17, 18, 23 Surface adsorption is a viable option for the use of nOM/DEGDMA because
of limited surface variation, which exists over the range of modulus. This would remove
the variability of protein adsorption conformation that exists with other materials and can
be verified by time of flight mass spectrometry.19
Modification of the surfaces by either specific ECM components or nonspecifically
adsorbed serum proteins allows an additional method to direct the cell function of VICs.
Controlling nonspecific protein adsorption onto the surfaces is attractive as it could allow
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for the same control offered from specific protein adsorption without the need to
purchase expensive animal derived proteins.

2.3. Further Valvular Interstitial Cell Expression Characterization
To investigate the impact of the substrate features on ECM production and
phenotypic expression, additional quantified methods can be used. Quantitative reverse
transcriptase-polymerase chain reaction (RT-qPCR) can be used to measure mRNA
expression of markers associated with activation, α-smooth muscle actin (αSMA), disease
(CBFa-1) and ECM proteins (pro-collagen, elastin) of VICs. Cells are lysed and mRNA
is isolated using an mRNA isolation kit (Qiagen) followed by reverse transcription
(Improm II-Reverse transcription kit, Promega) the cDNA is then amplified using qPCR.
Sybr Green provides the fluorescent signal when bound to dsDNA, this is an indication of
the concentration of the dsDNA in solution in situ during the PCR procedure. The control
gene for these experiments will be GAPDH which is associated with glycolysis.24 This
allows for determination of the fold change of expression of the mRNA of interest as
compared to the control gene. The use of qPCR for the quantification of expression is
attractive method as it samples an entire population of cells. RT-PCR could provide
additional level of understanding of the phenotypic gene expression and ECM secretion
by testing for specific marker genes. The reliance on mRNA allows the technique to be
much more sensitive to small changes in expression levels then immunocytochemistry
staining.
The discovery of the activated VIC (aVIC) cell surface markers such as vascular
endothelial growth factor receptor 2(VEGFR2) and angiotensin II Type 1 (AT1), could
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allow for the quantification of phenotypic expression levels without destruction of the
cell population prior to analysis.3 Using flow cytometry instead of immunocytochemistry
staining or RT-PCR offers rapid analysis of entire populations of VICs cultured on
various substrates. The identification of the osteoblastic-like VICs (obVICs) could also
be performed by assaying for the expression of receptor activator for nuclear factor
ligand (RANKL).3 Utilization of flow cytometry could allow for analysis of entire
populations to generate a greater understanding of the transition of between the different
VIC phenotypes.
The AV is composed of primarily type I collagen, but type III collagen (25%) also
makes up a significant portion of the valve. In diseased AV the production of both type I
and III collagens is shown to vary. 25 The changes in the ratio of type I to type III
collagen production could either be a byproduct of signaling pathways in disease or the
rigidity of the surrounding matrix. Evaluation of both the production of type I and III
collagens could give insight into the role of rigidity in the regulation of the type of ECM
produced by the VICs.
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